data_2l32_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l32 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' CB ' HG22 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 19' ' ' ASP . 21.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.79 0.329 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.45 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.472 HG11 ' CG1' ' A' ' 39' ' ' VAL . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' CB ' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.472 ' CG1' HG11 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HB ' HG11 ' A' ' 3' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.448 HG12 ' HB ' ' A' ' 37' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.447 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 37' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 20' ' ' ASP . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HB2' HG21 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 27' ' ' VAL . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 59' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 59' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 22.4 t . . . . . 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 5' ' ' VAL . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG12 ' CG2' ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' NH1' ' HB2' ' A' ' 18' ' ' ASP . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 ' HB ' HG13 ' A' ' 59' ' ' VAL . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' A' ' 37' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 56' ' ' ARG . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' HB ' ' A' ' 15' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 5' ' ' VAL . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.402 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 3' ' ' VAL . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 40' ' ' LEU . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' N ' HG13 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 ' CG1' ' A' ' 39' ' ' VAL . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' HG13 ' A' ' 59' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 17' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 37' ' ' VAL . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG22 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.425 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 15' ' ' VAL . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB1' ' HD3' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HD3' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.417 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 . . . . . 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HB ' HG12 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.13 0.491 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.867 0.365 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG12 ' HB ' ' A' ' 37' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.817 0.341 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 40' ' ' LEU . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' CG2' HG13 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.029 0.443 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 37' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 5' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 20' ' ' ASP . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.883 0.373 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 4' ' ' THR . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 20' ' ' ASP . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 56' ' ' ARG . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 20' ' ' ASP . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.454 ' CG2' HG13 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 3' ' ' VAL . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.454 HG13 ' CG2' ' A' ' 37' ' ' VAL . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 24' ' ' ALA . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' HG12 ' A' ' 59' ' ' VAL . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptt85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' CB ' HG22 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 19' ' ' ASP . 21.8 t -118.96 126.6 75.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -81.52 129.79 34.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.63 80.88 0.16 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.555 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -119.55 152.31 52.93 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.76 0.314 . . . . 0.0 111.206 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.31 120.55 7.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.777 2.318 . . . . 0.0 112.782 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.77 151.3 35.03 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.31 44.11 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.843 2.362 . . . . 0.0 112.555 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -9.3 38.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.523 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.12 19.15 8.28 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -97.9 -54.52 3.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.8 115.17 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t 65.38 94.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.296 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.09 81.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 128.57 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.3 -173.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.07 148.28 4.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.016 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -75.53 125.35 28.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.54 -93.68 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.614 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.825 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.45 HG11 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.472 HG11 ' CG1' ' A' ' 39' ' ' VAL . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' CB ' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.472 ' CG1' HG11 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.15 128.01 75.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.7 145.35 33.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.33 85.08 0.03 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.758 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 155.18 81.81 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.69 137.93 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.863 2.375 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.08 151.49 46.66 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.36 91.72 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.49 -17.98 65.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.715 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.26 16.51 5.16 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -96.73 -24.56 15.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t 60.55 41.51 15.47 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.104 0.478 . . . . 0.0 110.665 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.03 -35.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.58 47.63 1.6 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HB ' HG11 ' A' ' 3' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.14 140.82 24.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -52.67 133.75 36.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.149 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -145.21 144.46 21.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.208 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -134.65 139.0 44.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.62 -160.42 24.22 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.598 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.468 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.2 t -129.04 129.73 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -72.27 122.48 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.953 0.406 . . . . 0.0 110.962 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.23 87.55 0.32 Allowed Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.986 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.87 119.76 30.9 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.825 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.77 79.32 3.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.766 2.31 . . . . 0.0 112.614 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.96 90.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.528 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.06 102.01 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 0.0 112.382 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.0 -33.3 68.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.44 -18.46 28.26 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.42 12.21 7.15 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.22 111.07 6.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.588 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t 72.22 108.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.31 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.9 81.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.848 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.448 HG12 ' HB ' ' A' ' 37' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -59.81 136.62 58.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mt 61.98 -170.61 0.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 tt -115.88 156.72 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -55.01 40.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -154.36 24.1 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.0 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.904 179.849 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.73 131.17 73.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -81.57 127.86 33.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.647 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.79 72.11 1.07 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -118.34 133.78 23.47 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 122.083 0.153 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.53 110.99 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.784 2.323 . . . . 0.0 112.267 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 p -114.63 123.19 32.59 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 -15.55 38.21 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.717 2.278 . . . . 0.0 112.715 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.49 -9.82 51.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.601 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -8.76 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.858 -0.155 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -69.43 -38.78 78.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.784 0.326 . . . . 0.0 110.28 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 m -133.36 110.73 10.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t 71.34 95.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.171 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -66.31 82.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.237 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 133.14 55.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.68 82.77 6.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.937 0.399 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.68 -171.53 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -128.14 147.8 50.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.938 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.45 45.3 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.664 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.755 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 37' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 20' ' ' ASP . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HB2' HG21 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 27' ' ' VAL . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -123.35 131.21 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -80.0 130.11 35.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.0 86.49 0.06 OUTLIER Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.811 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 146.61 49.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.501 0.191 . . . . 0.0 110.794 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.65 109.95 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.83 2.353 . . . . 0.0 112.457 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.21 127.07 26.82 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.649 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.31 118.62 5.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.656 2.237 . . . . 0.0 112.182 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.29 -24.38 63.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.148 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.63 19.21 12.71 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.604 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.0 -65.75 0.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.6 t -168.02 84.08 0.19 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.701 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.3 p 41.02 38.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.95 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 54.29 52.8 11.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.12 113.97 1.07 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mp 59.28 -176.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.562 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.92 177.53 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.34 -71.94 0.67 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.58 109.61 0.4 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.601 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 59' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 59' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 22.4 t -122.35 127.29 75.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -81.43 126.14 31.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.762 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.16 86.2 0.8 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.479 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -114.7 144.96 32.9 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.267 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.87 63.7 6.73 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.138 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.12 147.89 35.64 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.83 -12.62 31.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.671 2.248 . . . . 0.0 112.955 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.27 -20.89 63.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.111 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.05 6.52 7.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -69.71 0.33 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.537 0.208 . . . . 0.0 111.0 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -96.39 110.42 22.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.322 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 t 70.0 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -69.8 81.65 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 5' ' ' VAL . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -51.97 134.46 31.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt 71.32 143.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 pt -76.07 167.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.261 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -78.56 154.91 29.99 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.5 -167.91 29.73 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.736 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.71 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.8 t -118.59 127.93 75.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -81.58 126.63 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.774 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.85 82.42 0.17 Allowed Glycine 0 C--N 1.336 0.56 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.617 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -123.93 149.53 60.11 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.136 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.16 109.85 2.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.815 2.343 . . . . 0.0 112.434 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 135.36 12.65 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.36 -20.4 18.51 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.568 2.179 . . . . 0.0 112.859 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.0 -17.06 61.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.222 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.16 -4.04 59.09 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -77.7 -65.85 0.91 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -81.33 125.71 30.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.443 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.9 t 80.52 -20.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.226 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 58.99 44.8 15.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -59.52 124.75 21.07 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.06 -168.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.099 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pt -148.24 122.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -141.52 33.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.274 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.76 -69.89 2.16 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.436 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG12 ' CG2' ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' NH1' ' HB2' ' A' ' 18' ' ' ASP . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 ' HB ' HG13 ' A' ' 59' ' ' VAL . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' CG2' HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.08 125.41 67.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.48 127.52 33.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.69 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 71.54 1.08 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.733 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.45 144.04 29.35 Favored Pre-proline 0 C--O 1.231 0.116 0 C-N-CA 122.083 0.153 . . . . 0.0 110.765 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.88 92.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.05 146.7 47.57 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.21 86.36 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.458 2.105 . . . . 0.0 111.935 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.49 -24.53 65.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.38 19.27 4.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.822 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -55.25 -60.49 3.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.568 0.223 . . . . 0.0 111.4 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.4 t -154.39 128.53 8.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG13 ' CG1' ' A' ' 54' ' ' VAL . 12.3 p 45.33 30.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.954 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 42.72 47.65 4.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 52' ' ' VAL . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' A' ' 37' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -63.89 119.02 9.24 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 59.3 176.77 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.322 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.87 134.01 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.418 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -146.7 121.9 10.18 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.04 -167.44 36.04 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.604 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.986 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 56' ' ' ARG . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG21 ' HB ' ' A' ' 15' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 5' ' ' VAL . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.402 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.68 130.96 73.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -81.42 127.77 33.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 71.67 1.6 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.377 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.94 128.61 21.58 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-O 120.506 0.193 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 138.74 80.48 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.905 2.404 . . . . 0.0 112.722 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.59 152.86 42.54 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.575 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 -16.34 36.74 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.621 2.214 . . . . 0.0 112.616 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.51 -17.52 55.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.529 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.9 -3.34 38.18 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -41.6 97.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.894 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -133.95 105.56 6.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t 68.97 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.241 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -65.29 81.22 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.957 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 3' ' ' VAL . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 40' ' ' LEU . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' N ' HG13 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -53.17 137.19 34.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.76 106.7 13.32 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.56 169.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -114.09 -47.44 2.95 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.109 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.23 96.29 0.15 Allowed Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.529 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.292 -1.282 . . . . 0.0 112.254 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 ' CG1' ' A' ' 39' ' ' VAL . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' HG13 ' A' ' 59' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 17' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.7 t -118.62 123.74 72.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.43 133.03 35.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.332 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.72 86.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.538 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -128.57 130.96 23.5 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.482 0.182 . . . . 0.0 111.078 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.77 131.56 42.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.912 2.408 . . . . 0.0 112.414 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.45 125.39 12.09 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.573 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.04 -14.15 21.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.725 2.283 . . . . 0.0 112.78 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.25 -12.21 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.74 -0.83 22.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -59.71 4.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.625 0.25 . . . . 0.0 110.693 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -133.3 18.99 4.0 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.6 t -152.09 87.05 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.428 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 80.44 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 37' ' ' VAL . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -62.89 123.11 17.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.451 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 3.0 mt 47.19 72.55 0.24 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.451 ' CG2' ' O ' ' A' ' 62' ' ' LEU . 9.3 tt 54.96 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.784 0.677 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -44.34 82.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.951 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.42 -44.26 0.23 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.622 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.347 179.681 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG22 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.425 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 15' ' ' VAL . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 t -116.98 128.51 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.3 143.96 31.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.333 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.8 84.2 0.05 OUTLIER Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.877 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -130.59 121.49 19.25 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-O 120.565 0.221 . . . . 0.0 111.007 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 125.2 18.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.8 2.333 . . . . 0.0 112.519 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.21 152.57 41.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.072 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.11 103.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.77 2.314 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -68.3 -15.25 63.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.249 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.46 16.47 15.2 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -91.31 -5.88 53.97 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.33 25.44 15.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 111.101 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -175.52 102.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.782 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 78.54 1.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -58.71 128.34 36.71 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.2 100.5 5.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.91 169.56 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.93 137.76 40.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.67 107.05 0.57 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.253 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.457 -1.19 . . . . 0.0 112.312 -179.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB1' ' HD3' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HD3' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.417 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.27 127.37 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.62 129.54 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.662 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 74.09 0.92 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.425 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.23 67.65 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 110.843 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.91 115.06 3.22 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.357 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.71 156.34 47.92 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.56 84.11 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.533 2.155 . . . . 0.0 112.312 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -68.05 -13.19 62.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.759 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -82.22 5.47 19.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.82 7.48 30.35 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t 73.69 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.488 0.315 . . . . 0.0 110.813 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 t 66.87 102.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.77 80.7 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 39' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -50.62 126.97 16.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.6 123.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.02 143.95 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 111.679 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -106.31 125.72 51.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.47 121.77 0.57 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.32 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.275 -1.292 . . . . 0.0 113.07 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HB ' HG12 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.2 t -118.44 123.11 71.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.7 140.71 35.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.54 84.49 0.1 Allowed Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 146.47 34.76 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.542 0.211 . . . . 0.0 110.912 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 68.85 3.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.642 2.228 . . . . 0.0 112.252 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.72 110.13 13.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.61 86.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.578 2.186 . . . . 0.0 112.25 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -13.46 62.32 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.612 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.94 18.56 4.1 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.08 -74.98 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.585 0.231 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.19 132.69 53.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.432 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 54' ' ' VAL . 4.4 p 47.19 94.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.627 0.58 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -54.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.902 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' VAL . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -61.35 125.99 25.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt 60.34 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.59 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.3 pt -142.96 147.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.628 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 153.32 20.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.46 117.79 5.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.604 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.55 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.05 138.62 54.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.55 122.44 26.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.314 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.77 -91.14 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.497 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.6 151.05 77.47 Favored Pre-proline 0 C--O 1.232 0.174 0 C-N-CA 122.385 0.274 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.5 126.8 9.89 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 111.958 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.58 100.84 15.15 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.01 87.99 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.614 2.21 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -26.03 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.616 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 6.3 m-20 -85.46 -18.56 33.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.612 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 84.57 -30.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.947 0.499 . . . . 0.0 111.722 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.39 138.5 40.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.2 t 67.33 103.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.249 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.75 78.47 0.11 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.441 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.478 HG12 ' HB ' ' A' ' 37' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -59.36 128.13 35.54 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.8 -173.92 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.5 156.26 29.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.22 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 138.03 39.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.86 102.25 0.75 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.591 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.789 -1.006 . . . . 0.0 113.011 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.73 125.7 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.56 140.52 34.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.337 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.33 84.9 0.13 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.307 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -122.4 158.74 55.15 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 44' ' ' ARG . 52.5 Cg_endo -69.43 146.54 62.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.862 2.375 . . . . 0.0 112.835 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.05 139.1 16.39 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.732 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -51.64 107.83 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.788 2.325 . . . . 0.0 112.585 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -14.92 63.36 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.482 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -76.69 -8.71 57.8 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.47 62.15 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.27 27.06 12.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.889 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p 179.14 105.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.812 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.13 80.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 40' ' ' LEU . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -59.3 128.53 37.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.43 178.33 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.2 pt -127.4 159.33 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.263 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -144.98 76.4 1.49 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.78 136.78 4.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.395 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.58 -1.122 . . . . 0.0 112.824 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 59' ' ' VAL . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' CG2' HG13 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -127.36 130.8 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -80.89 127.04 32.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.32 87.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.719 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -131.32 142.36 45.17 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 120.426 0.155 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 98.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.748 2.298 . . . . 0.0 112.122 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -106.4 105.64 54.94 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.6 -12.09 32.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.579 2.186 . . . . 0.0 112.739 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -60.67 -18.73 55.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.588 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -77.93 1.53 20.34 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.62 -55.53 25.04 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.516 0.198 . . . . 0.0 110.971 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -125.22 26.06 7.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.681 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.5 p -176.3 99.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 120.938 0.399 . . . . 0.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.55 78.12 0.41 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.446 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 37' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.31 131.94 33.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mp 61.76 168.02 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.236 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.7 pt -104.21 136.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.933 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -60.52 -43.69 96.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.79 -91.24 0.08 OUTLIER Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.322 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.502 -1.165 . . . . 0.0 112.729 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 5' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 20' ' ' ASP . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 64' ' ' LYS . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.61 130.89 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.81 123.26 28.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.304 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.6 74.17 2.54 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -123.18 157.17 61.8 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.565 0.221 . . . . 0.0 110.949 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.08 106.84 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.023 2.482 . . . . 0.0 112.886 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.44 146.95 31.78 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 -10.99 25.04 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.804 2.336 . . . . 0.0 112.892 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.96 -21.43 61.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.212 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.57 19.17 2.05 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -113.08 -69.17 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.616 0.246 . . . . 0.0 110.569 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -85.47 98.78 10.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t 70.3 105.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.21 79.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.158 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 37' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -50.91 140.34 15.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 72.26 175.26 0.28 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.5 tp -84.7 144.26 10.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.928 0.394 . . . . 0.0 111.212 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -105.9 172.96 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.66 -146.54 12.28 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.917 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.505 -1.164 . . . . 0.0 112.559 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 4' ' ' THR . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 3' ' ' VAL . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 20' ' ' ASP . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.41 126.27 71.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -81.38 130.98 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.576 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.15 83.06 0.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.387 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -130.39 155.65 80.69 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.33 . . . . 0.0 111.163 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 141.75 45.65 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG22 ' HD2' ' A' ' 47' ' ' PRO . 12.1 p -162.54 128.02 2.2 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.297 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 46' ' ' VAL . 33.3 Cg_endo -64.14 -15.17 47.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.643 2.229 . . . . 0.0 112.894 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -66.99 -13.74 62.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.15 -17.79 59.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.24 -53.11 11.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.714 0.292 . . . . 0.0 110.415 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 115.91 30.55 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.186 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 t 70.37 100.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.215 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.28 81.81 0.05 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -53.87 133.39 42.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.81 162.5 0.11 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 pt -118.18 148.01 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.291 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -166.87 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.4 133.34 6.24 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.28 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.069 179.809 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 56' ' ' ARG . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 20' ' ' ASP . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.454 ' CG2' HG13 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -122.57 129.88 74.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.4 126.74 31.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.969 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.49 86.95 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.472 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 141.41 22.79 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.456 0.169 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.45 -27.52 40.43 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.928 2.419 . . . . 0.0 112.717 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.92 135.4 87.27 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.6 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.8 55.63 5.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.64 2.226 . . . . 0.0 112.167 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -13.78 60.82 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.24 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -98.82 18.96 15.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.614 0.245 . . . . 0.0 111.553 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.39 18.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 110.776 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.29 105.74 17.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.68 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 69.9 6.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.838 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 1.9 mt-10 50.84 37.16 16.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 3' ' ' VAL . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.454 HG13 ' CG2' ' A' ' 37' ' ' VAL . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -59.75 136.15 57.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.422 ' N ' HG11 ' A' ' 37' ' ' VAL . 13.3 tp 65.54 161.66 0.14 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.84 143.29 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -140.25 154.66 46.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -162.4 30.03 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.65 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -1.311 . . . . 0.0 112.887 179.833 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 24' ' ' ALA . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' HG12 ' A' ' 59' ' ' VAL . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.99 129.28 74.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.27 128.54 33.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.37 86.57 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.649 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 138.01 31.99 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.488 0.185 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 91.87 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.518 2.146 . . . . 0.0 112.128 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.73 157.17 34.69 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.97 105.12 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.695 2.263 . . . . 0.0 112.642 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -13.76 62.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -5.17 49.57 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -58.63 -27.17 64.46 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.326 0.108 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 t 74.8 152.16 0.13 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.5 t 75.82 -4.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.073 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 47.56 51.31 13.96 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.413 HG12 ' HB ' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptt85 -50.69 137.68 19.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.41 32.09 6.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.1 tp -99.77 147.68 7.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 167.53 10.79 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.99 178.58 25.06 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.923 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.504 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 ' H ' ' A' ' 55' ' ' ASP . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 ' HD3' ' A' ' 56' ' ' ARG . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 57' ' ' VAL . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 60' ' ' LEU . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 5' ' ' VAL . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 39' ' ' VAL . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 17' ' ' VAL . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.72 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.599 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 38' ' ' THR . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.791 HG21 HG22 ' A' ' 17' ' ' VAL . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HG11 ' A' ' 57' ' ' VAL . 21.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.79 0.329 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' H ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HD3' HG23 ' A' ' 4' ' ' THR . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.856 HG11 HG22 ' A' ' 41' ' ' VAL . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.784 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 HG21 ' A' ' 59' ' ' VAL . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 ' CG2' ' A' ' 37' ' ' VAL . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' ASP . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.659 ' CG2' HG21 ' A' ' 15' ' ' VAL . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 HG21 ' A' ' 57' ' ' VAL . 22.1 t . . . . . 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' HG12 ' A' ' 3' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG21 HG22 ' A' ' 41' ' ' VAL . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.521 ' N ' HG12 ' A' ' 57' ' ' VAL . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 37' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' CG1' ' A' ' 37' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.675 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 55' ' ' ASP . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' HB ' ' A' ' 15' ' ' VAL . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' HG21 ' A' ' 5' ' ' VAL . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 24' ' ' ALA . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.686 ' NH2' HG12 ' A' ' 39' ' ' VAL . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 59' ' ' VAL . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.686 HG12 ' NH2' ' A' ' 28' ' ' ARG . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.2 t . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' OD1' ' A' ' 20' ' ' ASP . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 41' ' ' VAL . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 60' ' ' LEU . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 57' ' ' VAL . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' A' ' 59' ' ' VAL . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 16' ' ' ALA . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 HG11 ' A' ' 57' ' ' VAL . 18.7 t . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.447 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 39' ' ' VAL . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.901 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 17' ' ' VAL . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.744 ' CG1' HG22 ' A' ' 59' ' ' VAL . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.864 HG12 HG23 ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 3' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 39' ' ' VAL . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.901 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 17' ' ' VAL . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 57' ' ' VAL . 25.5 t . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' CB ' HG12 ' A' ' 3' ' ' VAL . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 41' ' ' VAL . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 57' ' ' VAL . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 37' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE2' HG11 ' A' ' 54' ' ' VAL . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 37' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 30' ' ' VAL . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.696 ' O ' HG12 ' A' ' 59' ' ' VAL . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG21 HG12 ' A' ' 17' ' ' VAL . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG22 HG11 ' A' ' 57' ' ' VAL . 22.4 t . . . . . 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 1' ' ' MET . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' A' ' 39' ' ' VAL . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 38' ' ' THR . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 57' ' ' VAL . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG21 HH12 ' A' ' 61' ' ' ARG . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 37' ' ' VAL . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' A' ' 57' ' ' VAL . 20.8 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 41' ' ' VAL . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.57 HH12 HG21 ' A' ' 7' ' ' VAL . 8.5 mtt85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 37' ' ' VAL . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG21 ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 41' ' ' VAL . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.471 HH21 HG12 ' A' ' 39' ' ' VAL . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 15' ' ' VAL . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG21 HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' ASP . 21.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 7' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 57' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.426 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.607 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 58' ' ' LYS . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 59' ' ' VAL . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' VAL . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 37' ' ' VAL . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 28' ' ' ARG . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 20' ' ' ASP . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.773 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 32' ' ' LEU . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 15' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.601 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 59' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.587 ' HA ' HG11 ' A' ' 57' ' ' VAL . 25.7 t . . . . . 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 41' ' ' VAL . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 38' ' ' THR . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.742 ' H1 ' ' HB3' ' A' ' 24' ' ' ALA . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.972 HG12 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' VAL . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 61' ' ' ARG . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.972 HG21 HG12 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' HG11 ' A' ' 57' ' ' VAL . 26.3 t . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 41' ' ' VAL . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 39' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 37' ' ' VAL . 1.3 mtp85 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 12' ' ' THR . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 60' ' ' LEU . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 6' ' ' GLU . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 37' ' ' VAL . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 39' ' ' VAL . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.657 ' CB ' HG11 ' A' ' 41' ' ' VAL . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.705 ' HG2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 30' ' ' VAL . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 15' ' ' VAL . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' HG12 ' A' ' 17' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.906 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 19' ' ' ASP . 86.0 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.906 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' H ' HG12 ' A' ' 57' ' ' VAL . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 7' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 8' ' ' VAL . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 . . . . . 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.817 HG11 ' O ' ' A' ' 55' ' ' ASP . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 59' ' ' VAL . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG12 HG21 ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG2' HG11 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HG12 ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 57' ' ' VAL . 36.2 t . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.13 0.491 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.817 ' O ' HG11 ' A' ' 3' ' ' VAL . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 39' ' ' VAL . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.645 HG11 ' CG2' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HA ' HG11 ' A' ' 37' ' ' VAL . 2.2 ptt85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 17' ' ' VAL . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 57' ' ' VAL . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 39' ' ' VAL . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.57 ' H ' HG22 ' A' ' 22' ' ' THR . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 24' ' ' ALA . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.586 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 19' ' ' ASP . 41.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.867 0.365 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 3' ' ' VAL . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB2' HG13 ' A' ' 7' ' ' VAL . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 37' ' ' VAL . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.814 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 16' ' ' ALA . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 59' ' ' VAL . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 17' ' ' VAL . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.064 HG22 HG21 ' A' ' 57' ' ' VAL . 22.5 t . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.817 0.341 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.064 HG21 HG22 ' A' ' 41' ' ' VAL . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' HG23 ' A' ' 7' ' ' VAL . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' H ' HG22 ' A' ' 22' ' ' THR . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.823 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.823 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HG12 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 57' ' ' VAL . 16.9 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.029 0.443 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 7' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG12 HG23 ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 37' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 39' ' ' VAL . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 30' ' ' VAL . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 15' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 17' ' ' VAL . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.833 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 57' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.883 0.373 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.755 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 HG12 ' A' ' 7' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.5 ttt180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 24' ' ' ALA . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' O ' ' A' ' 55' ' ' ASP . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 57' ' ' VAL . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG12 HG21 ' A' ' 39' ' ' VAL . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.606 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' H ' HG22 ' A' ' 22' ' ' THR . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 30' ' ' VAL . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 30' ' ' VAL . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 59' ' ' VAL . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.771 HG21 HG12 ' A' ' 17' ' ' VAL . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.585 ' HA ' HG11 ' A' ' 57' ' ' VAL . 21.3 t . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.89 ' O ' HG11 ' A' ' 3' ' ' VAL . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 41' ' ' VAL . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 37' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.908 HG11 ' O ' ' A' ' 55' ' ' ASP . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG21 ' HB ' ' A' ' 15' ' ' VAL . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 59' ' ' VAL . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' HG21 ' A' ' 5' ' ' VAL . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.956 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' H ' HG22 ' A' ' 22' ' ' THR . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.532 ' HB ' HG12 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 17' ' ' VAL . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 19' ' ' ASP . 19.5 t . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.908 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 41' ' ' VAL . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 38' ' ' THR . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 55' ' ' ASP . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 15' ' ' VAL . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG2' HG21 ' A' ' 5' ' ' VAL . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 27' ' ' VAL . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD13 HG13 ' A' ' 30' ' ' VAL . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 61' ' ' ARG . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 16' ' ' ALA . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 57' ' ' VAL . 13.7 t . . . . . 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.753 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 41' ' ' VAL . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.678 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.711 ' HA ' HG11 ' A' ' 37' ' ' VAL . 16.2 ptt85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 ' H ' ' A' ' 55' ' ' ASP . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 ' HD3' ' A' ' 56' ' ' ARG . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 57' ' ' VAL . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 60' ' ' LEU . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 5' ' ' VAL . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 39' ' ' VAL . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 17' ' ' VAL . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.72 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 38' ' ' THR . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.791 HG21 HG22 ' A' ' 17' ' ' VAL . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HG11 ' A' ' 57' ' ' VAL . 21.8 t -118.96 126.6 75.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -81.52 129.79 34.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.63 80.88 0.16 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.555 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -119.55 152.31 52.93 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.76 0.314 . . . . 0.0 111.206 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.31 120.55 7.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.777 2.318 . . . . 0.0 112.782 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.77 151.3 35.03 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.31 44.11 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.843 2.362 . . . . 0.0 112.555 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -9.3 38.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.523 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.12 19.15 8.28 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -97.9 -54.52 3.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.8 115.17 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.905 HG12 HG13 ' A' ' 54' ' ' VAL . 24.9 t 65.38 94.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.296 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.09 81.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.905 HG13 HG12 ' A' ' 52' ' ' VAL . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' H ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HD3' HG23 ' A' ' 4' ' ' THR . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.856 HG11 HG22 ' A' ' 41' ' ' VAL . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 128.57 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.3 -173.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.07 148.28 4.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.016 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -75.53 125.35 28.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.54 -93.68 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.614 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.825 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.784 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 HG21 ' A' ' 59' ' ' VAL . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 ' CG2' ' A' ' 37' ' ' VAL . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' ASP . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.723 ' O ' HD23 ' A' ' 62' ' ' LEU . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.659 ' CG2' HG21 ' A' ' 15' ' ' VAL . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 HG21 ' A' ' 57' ' ' VAL . 22.1 t -118.15 128.01 75.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.7 145.35 33.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.33 85.08 0.03 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.758 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 155.18 81.81 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.69 137.93 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.863 2.375 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.08 151.49 46.66 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.36 91.72 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.49 -17.98 65.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.715 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.26 16.51 5.16 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' VAL . 2.9 mm-40 -96.73 -24.56 15.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t 60.55 41.51 15.47 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.104 0.478 . . . . 0.0 110.665 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.763 HG22 HG13 ' A' ' 54' ' ' VAL . 10.7 p -150.03 -35.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.975 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.58 47.63 1.6 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 52' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG21 HG22 ' A' ' 41' ' ' VAL . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.521 ' N ' HG12 ' A' ' 57' ' ' VAL . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 37' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' CG1' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -53.14 140.82 24.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 35' ' ' HIS . 3.7 pp -52.67 133.75 36.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.149 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -145.21 144.46 21.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.208 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -134.65 139.0 44.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.62 -160.42 24.22 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.598 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.468 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.675 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 55' ' ' ASP . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' HB ' ' A' ' 15' ' ' VAL . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' HG21 ' A' ' 5' ' ' VAL . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 24' ' ' ALA . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.686 ' NH2' HG12 ' A' ' 39' ' ' VAL . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 59' ' ' VAL . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.686 HG12 ' NH2' ' A' ' 28' ' ' ARG . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.2 t -129.04 129.73 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 14.9 p-10 -72.27 122.48 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.953 0.406 . . . . 0.0 110.962 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.23 87.55 0.32 Allowed Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.986 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG3' ' OD2' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -119.87 119.76 30.9 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.825 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.77 79.32 3.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.766 2.31 . . . . 0.0 112.614 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -172.96 90.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.528 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.06 102.01 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 0.0 112.382 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.0 -33.3 68.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.44 -18.46 28.26 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.42 12.21 7.15 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.22 111.07 6.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.588 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.824 HG12 HG13 ' A' ' 54' ' ' VAL . 23.4 t 72.22 108.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.31 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.9 81.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.848 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.824 HG13 HG12 ' A' ' 52' ' ' VAL . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 41' ' ' VAL . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 60' ' ' LEU . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -59.81 136.62 58.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.6 mt 61.98 -170.61 0.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 tt -115.88 156.72 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -55.01 40.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -154.36 24.1 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.0 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.904 179.849 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 57' ' ' VAL . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.819 ' HA ' HD13 ' A' ' 62' ' ' LEU . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 16' ' ' ALA . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 HG11 ' A' ' 57' ' ' VAL . 18.7 t -123.73 131.17 73.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -81.57 127.86 33.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.647 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.79 72.11 1.07 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -118.34 133.78 23.47 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 122.083 0.153 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.53 110.99 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.784 2.323 . . . . 0.0 112.267 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 48' ' ' GLU . 14.1 p -114.63 123.19 32.59 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 -15.55 38.21 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.717 2.278 . . . . 0.0 112.715 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' VAL . 19.1 mt-10 -68.49 -9.82 51.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.601 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -8.76 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.858 -0.155 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -69.43 -38.78 78.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.784 0.326 . . . . 0.0 110.28 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 m -133.36 110.73 10.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 54' ' ' VAL . 12.7 t 71.34 95.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.171 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -66.31 82.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.237 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 52' ' ' VAL . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 39' ' ' VAL . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' CG ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -57.91 133.14 55.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.819 HD13 ' HA ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -88.68 82.77 6.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.937 0.399 . . . . 0.0 110.939 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -127.68 -171.53 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.752 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 63' ' ' ILE . 13.9 mmtm -128.14 147.8 50.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.45 45.3 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.664 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.755 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.901 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 17' ' ' VAL . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.744 ' CG1' HG22 ' A' ' 59' ' ' VAL . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.864 HG12 HG23 ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 3' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 39' ' ' VAL . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.901 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 17' ' ' VAL . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 57' ' ' VAL . 25.5 t -123.35 131.21 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -80.0 130.11 35.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.0 86.49 0.06 OUTLIER Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.811 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -123.01 146.61 49.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.501 0.191 . . . . 0.0 110.794 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.65 109.95 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.83 2.353 . . . . 0.0 112.457 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 44' ' ' ARG . 21.7 t -118.21 127.07 26.82 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.649 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.31 118.62 5.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.656 2.237 . . . . 0.0 112.182 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.29 -24.38 63.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.148 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.63 19.21 12.71 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.604 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.0 -65.75 0.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.749 ' O ' HG22 ' A' ' 54' ' ' VAL . 45.6 t -168.02 84.08 0.19 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.71 HG13 HG13 ' A' ' 54' ' ' VAL . 9.3 p 41.02 38.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.95 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 54.29 52.8 11.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 51' ' ' SER . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 41' ' ' VAL . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 57' ' ' VAL . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 37' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.12 113.97 1.07 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mp 59.28 -176.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.562 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.92 177.53 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.34 -71.94 0.67 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.58 109.61 0.4 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.601 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE2' HG11 ' A' ' 54' ' ' VAL . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 37' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 30' ' ' VAL . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 63' ' ' ILE . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.696 ' O ' HG12 ' A' ' 59' ' ' VAL . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG21 HG12 ' A' ' 17' ' ' VAL . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG22 HG11 ' A' ' 57' ' ' VAL . 22.4 t -122.35 127.29 75.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -81.43 126.14 31.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.762 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.16 86.2 0.8 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.479 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -114.7 144.96 32.9 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.267 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.87 63.7 6.73 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.138 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.12 147.89 35.64 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.83 -12.62 31.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.671 2.248 . . . . 0.0 112.955 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.27 -20.89 63.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.111 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.05 6.52 7.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -69.71 0.33 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.537 0.208 . . . . 0.0 111.0 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -96.39 110.42 22.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.322 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.758 HG12 HG13 ' A' ' 54' ' ' VAL . 18.8 t 70.0 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -69.8 81.65 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG13 HG12 ' A' ' 52' ' ' VAL . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' A' ' 39' ' ' VAL . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 38' ' ' THR . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -51.97 134.46 31.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt 71.32 143.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 36' ' ' GLU . 7.0 pt -76.07 167.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.261 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -78.56 154.91 29.99 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.5 -167.91 29.73 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.736 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.71 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 57' ' ' VAL . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG21 HH12 ' A' ' 61' ' ' ARG . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 37' ' ' VAL . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' A' ' 57' ' ' VAL . 20.8 t -118.59 127.93 75.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -81.58 126.63 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.774 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.85 82.42 0.17 Allowed Glycine 0 C--N 1.336 0.56 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.617 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -123.93 149.53 60.11 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.136 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.16 109.85 2.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.815 2.343 . . . . 0.0 112.434 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 135.36 12.65 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.36 -20.4 18.51 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.568 2.179 . . . . 0.0 112.859 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.0 -17.06 61.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.222 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.16 -4.04 59.09 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -77.7 -65.85 0.91 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' C ' HG23 ' A' ' 52' ' ' VAL . 1.4 m -81.33 125.71 30.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.443 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 54' ' ' VAL . 4.9 t 80.52 -20.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.226 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 58.99 44.8 15.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG13 HG12 ' A' ' 52' ' ' VAL . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 41' ' ' VAL . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.57 HH12 HG21 ' A' ' 7' ' ' VAL . 8.5 mtt85 -59.52 124.75 21.07 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 37' ' ' VAL . 0.1 OUTLIER 56.06 -168.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.099 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pt -148.24 122.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -141.52 33.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.274 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.76 -69.89 2.16 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.436 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 37' ' ' VAL . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG21 ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 41' ' ' VAL . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.471 HH21 HG12 ' A' ' 39' ' ' VAL . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG12 ' H ' ' A' ' 62' ' ' LEU . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG21 HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' ASP . 21.3 t -126.08 125.41 67.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.48 127.52 33.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.69 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 71.54 1.08 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.733 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -110.45 144.04 29.35 Favored Pre-proline 0 C--O 1.231 0.116 0 C-N-CA 122.083 0.153 . . . . 0.0 110.765 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 52.0 Cg_exo -55.88 92.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 44' ' ' ARG . 30.1 m -140.05 146.7 47.57 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.21 86.36 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.458 2.105 . . . . 0.0 111.935 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.49 -24.53 65.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.38 19.27 4.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.822 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -55.25 -60.49 3.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.568 0.223 . . . . 0.0 111.4 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.4 t -154.39 128.53 8.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.799 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.937 HG13 HG13 ' A' ' 54' ' ' VAL . 12.3 p 45.33 30.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.954 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 42.72 47.65 4.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.937 HG13 HG13 ' A' ' 52' ' ' VAL . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 7' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -63.89 119.02 9.24 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.804 ' H ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER 59.3 176.77 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.322 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.87 134.01 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.418 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -146.7 121.9 10.18 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.04 -167.44 36.04 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.604 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.986 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 57' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.607 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.68 130.96 73.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -81.42 127.77 33.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 71.67 1.6 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.377 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.94 128.61 21.58 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-O 120.506 0.193 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 138.74 80.48 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.905 2.404 . . . . 0.0 112.722 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.59 152.86 42.54 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.575 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 -16.34 36.74 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.621 2.214 . . . . 0.0 112.616 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.51 -17.52 55.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.529 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.9 -3.34 38.18 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -41.6 97.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.894 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -133.95 105.56 6.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 54' ' ' VAL . 10.9 t 68.97 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.241 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -65.29 81.22 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.957 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 58' ' ' LYS . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -53.17 137.19 34.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -117.76 106.7 13.32 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.56 169.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -114.09 -47.44 2.95 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.109 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.23 96.29 0.15 Allowed Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.529 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.292 -1.282 . . . . 0.0 112.254 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 59' ' ' VAL . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' VAL . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 37' ' ' VAL . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 28' ' ' ARG . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 20' ' ' ASP . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.773 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 32' ' ' LEU . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 15' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.601 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 59' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.587 ' HA ' HG11 ' A' ' 57' ' ' VAL . 25.7 t -118.62 123.74 72.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.43 133.03 35.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.332 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.72 86.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.538 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -128.57 130.96 23.5 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.482 0.182 . . . . 0.0 111.078 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.77 131.56 42.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.912 2.408 . . . . 0.0 112.414 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.45 125.39 12.09 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.573 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.04 -14.15 21.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.725 2.283 . . . . 0.0 112.78 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.25 -12.21 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.74 -0.83 22.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -59.71 4.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.625 0.25 . . . . 0.0 110.693 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -133.3 18.99 4.0 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 54' ' ' VAL . 25.6 t -152.09 87.05 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.428 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 80.44 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 52' ' ' VAL . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 41' ' ' VAL . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 38' ' ' THR . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -62.89 123.11 17.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.72 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.0 mt 47.19 72.55 0.24 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 62' ' ' LEU . 9.3 tt 54.96 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.784 0.677 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -44.34 82.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.951 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.42 -44.26 0.23 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.622 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.347 179.681 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.742 ' H1 ' ' HB3' ' A' ' 24' ' ' ALA . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.972 HG12 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' VAL . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 61' ' ' ARG . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.972 HG21 HG12 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' HG11 ' A' ' 57' ' ' VAL . 26.3 t -116.98 128.51 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.3 143.96 31.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.333 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.8 84.2 0.05 OUTLIER Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.877 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -130.59 121.49 19.25 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-O 120.565 0.221 . . . . 0.0 111.007 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 125.2 18.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.8 2.333 . . . . 0.0 112.519 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.21 152.57 41.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.072 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.11 103.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.77 2.314 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -68.3 -15.25 63.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.249 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.46 16.47 15.2 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -91.31 -5.88 53.97 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.33 25.44 15.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 111.101 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.991 HG22 HG13 ' A' ' 54' ' ' VAL . 7.1 p -175.52 102.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.782 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 78.54 1.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.991 HG13 HG22 ' A' ' 52' ' ' VAL . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 41' ' ' VAL . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 39' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 37' ' ' VAL . 1.3 mtp85 -58.71 128.34 36.71 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.2 100.5 5.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.91 169.56 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.93 137.76 40.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.67 107.05 0.57 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.253 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.457 -1.19 . . . . 0.0 112.312 -179.701 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 12' ' ' THR . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 60' ' ' LEU . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 6' ' ' GLU . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 37' ' ' VAL . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 39' ' ' VAL . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.657 ' CB ' HG11 ' A' ' 41' ' ' VAL . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.705 ' HG2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 30' ' ' VAL . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 15' ' ' VAL . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' HG12 ' A' ' 17' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.906 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 19' ' ' ASP . 86.0 t -130.27 127.37 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.62 129.54 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.662 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 74.09 0.92 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.425 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.23 67.65 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 110.843 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.91 115.06 3.22 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.357 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.71 156.34 47.92 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.56 84.11 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.533 2.155 . . . . 0.0 112.312 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -68.05 -13.19 62.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.759 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -82.22 5.47 19.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.82 7.48 30.35 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t 73.69 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.488 0.315 . . . . 0.0 110.813 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 54' ' ' VAL . 12.5 t 66.87 102.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.77 80.7 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 52' ' ' VAL . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.906 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' H ' HG12 ' A' ' 57' ' ' VAL . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 7' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 8' ' ' VAL . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -50.62 126.97 16.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.6 123.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.02 143.95 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 111.679 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -106.31 125.72 51.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.47 121.77 0.57 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.32 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.275 -1.292 . . . . 0.0 113.07 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.817 HG11 ' O ' ' A' ' 55' ' ' ASP . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 59' ' ' VAL . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG12 HG21 ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG2' HG11 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' HD11 ' A' ' 63' ' ' ILE . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HG12 ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 57' ' ' VAL . 36.2 t -118.44 123.11 71.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.7 140.71 35.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.54 84.49 0.1 Allowed Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -111.66 146.47 34.76 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.542 0.211 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 44' ' ' ARG . 60.8 Cg_endo -72.53 68.85 3.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.642 2.228 . . . . 0.0 112.252 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 46' ' ' VAL . 12.2 m -132.72 110.13 13.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.61 86.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.578 2.186 . . . . 0.0 112.25 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -13.46 62.32 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.612 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.94 18.56 4.1 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.08 -74.98 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.585 0.231 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.19 132.69 53.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.432 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 p 47.19 94.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.627 0.58 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -54.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.902 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 52' ' ' VAL . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.817 ' O ' HG11 ' A' ' 3' ' ' VAL . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 39' ' ' VAL . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.645 HG11 ' CG2' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HA ' HG11 ' A' ' 37' ' ' VAL . 2.2 ptt85 -61.35 125.99 25.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt 60.34 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.59 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.647 HD11 ' HB ' ' A' ' 38' ' ' THR . 20.3 pt -142.96 147.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.628 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 153.32 20.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.46 117.79 5.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.604 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.55 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 17' ' ' VAL . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 57' ' ' VAL . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 39' ' ' VAL . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.57 ' H ' HG22 ' A' ' 22' ' ' THR . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 24' ' ' ALA . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.586 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 19' ' ' ASP . 41.5 t -128.05 138.62 54.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.55 122.44 26.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.314 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.77 -91.14 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.497 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.6 151.05 77.47 Favored Pre-proline 0 C--O 1.232 0.174 0 C-N-CA 122.385 0.274 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.5 126.8 9.89 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 111.958 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.58 100.84 15.15 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.01 87.99 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.614 2.21 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -26.03 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.616 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 6.3 m-20 -85.46 -18.56 33.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.612 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 84.57 -30.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.947 0.499 . . . . 0.0 111.722 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.39 138.5 40.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 54' ' ' VAL . 18.2 t 67.33 103.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.249 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.75 78.47 0.11 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.441 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 52' ' ' VAL . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 3' ' ' VAL . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -59.36 128.13 35.54 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' H ' HG12 ' A' ' 37' ' ' VAL . 0.5 OUTLIER 57.8 -173.92 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 pp -123.5 156.26 29.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.22 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 138.03 39.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.86 102.25 0.75 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.591 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.789 -1.006 . . . . 0.0 113.011 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB2' HG13 ' A' ' 7' ' ' VAL . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 37' ' ' VAL . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.814 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 16' ' ' ALA . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 59' ' ' VAL . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 17' ' ' VAL . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.064 HG22 HG21 ' A' ' 57' ' ' VAL . 22.5 t -119.73 125.7 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.56 140.52 34.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.337 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.33 84.9 0.13 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.307 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -122.4 158.74 55.15 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 44' ' ' ARG . 52.5 Cg_endo -69.43 146.54 62.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.862 2.375 . . . . 0.0 112.835 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.05 139.1 16.39 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.732 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -51.64 107.83 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.788 2.325 . . . . 0.0 112.585 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -14.92 63.36 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.482 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -76.69 -8.71 57.8 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.47 62.15 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.27 27.06 12.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.889 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.895 HG22 HG13 ' A' ' 54' ' ' VAL . 7.7 p 179.14 105.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.812 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.13 80.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 52' ' ' VAL . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.064 HG21 HG22 ' A' ' 41' ' ' VAL . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' HG23 ' A' ' 7' ' ' VAL . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -59.3 128.53 37.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.43 178.33 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.2 pt -127.4 159.33 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.263 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -144.98 76.4 1.49 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.78 136.78 4.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.395 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.58 -1.122 . . . . 0.0 112.824 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' H ' HG22 ' A' ' 22' ' ' THR . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.823 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.823 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 62' ' ' LEU . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HG12 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 57' ' ' VAL . 16.9 t -127.36 130.8 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -80.89 127.04 32.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.32 87.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.719 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -131.32 142.36 45.17 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 120.426 0.155 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 98.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.748 2.298 . . . . 0.0 112.122 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.1 p -106.4 105.64 54.94 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.6 -12.09 32.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.579 2.186 . . . . 0.0 112.739 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -60.67 -18.73 55.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.588 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.1 p30 -77.93 1.53 20.34 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.62 -55.53 25.04 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.516 0.198 . . . . 0.0 110.971 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -125.22 26.06 7.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.681 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 54' ' ' VAL . 7.5 p -176.3 99.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 120.938 0.399 . . . . 0.0 110.477 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.55 78.12 0.41 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.446 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 52' ' ' VAL . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 7' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.31 131.94 33.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.3 mp 61.76 168.02 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.7 pt -104.21 136.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.933 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -60.52 -43.69 96.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.79 -91.24 0.08 OUTLIER Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.322 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.502 -1.165 . . . . 0.0 112.729 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG12 HG23 ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 37' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 39' ' ' VAL . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 30' ' ' VAL . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 15' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 64' ' ' LYS . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 17' ' ' VAL . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.833 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 57' ' ' VAL . 16.6 t -120.61 130.89 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.81 123.26 28.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.304 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.6 74.17 2.54 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -123.18 157.17 61.8 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.565 0.221 . . . . 0.0 110.949 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.08 106.84 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.023 2.482 . . . . 0.0 112.886 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.44 146.95 31.78 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 -10.99 25.04 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.804 2.336 . . . . 0.0 112.892 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.96 -21.43 61.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.212 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.57 19.17 2.05 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -113.08 -69.17 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.616 0.246 . . . . 0.0 110.569 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -85.47 98.78 10.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 54' ' ' VAL . 12.2 t 70.3 105.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.21 79.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.158 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 52' ' ' VAL . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.755 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 HG12 ' A' ' 7' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.5 ttt180 -50.91 140.34 15.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 72.26 175.26 0.28 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.5 tp -84.7 144.26 10.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.928 0.394 . . . . 0.0 111.212 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HB2' HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -105.9 172.96 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.66 -146.54 12.28 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.917 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.505 -1.164 . . . . 0.0 112.559 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 24' ' ' ALA . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' O ' ' A' ' 55' ' ' ASP . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 57' ' ' VAL . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG12 HG21 ' A' ' 39' ' ' VAL . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.606 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' H ' HG22 ' A' ' 22' ' ' THR . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 30' ' ' VAL . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 30' ' ' VAL . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 63' ' ' ILE . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 59' ' ' VAL . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.771 HG21 HG12 ' A' ' 17' ' ' VAL . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.585 ' HA ' HG11 ' A' ' 57' ' ' VAL . 21.3 t -124.41 126.27 71.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -81.38 130.98 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.576 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.15 83.06 0.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.387 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -130.39 155.65 80.69 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.33 . . . . 0.0 111.163 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 141.75 45.65 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 48' ' ' GLU . 12.1 p -162.54 128.02 2.2 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.297 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.14 -15.17 47.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.643 2.229 . . . . 0.0 112.894 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.687 ' H ' HG22 ' A' ' 46' ' ' VAL . 30.2 mm-40 -66.99 -13.74 62.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.379 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.15 -17.79 59.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.24 -53.11 11.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.714 0.292 . . . . 0.0 110.415 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 115.91 30.55 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.186 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 54' ' ' VAL . 18.0 t 70.37 100.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.215 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.28 81.81 0.05 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 52' ' ' VAL . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.89 ' O ' HG11 ' A' ' 3' ' ' VAL . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 41' ' ' VAL . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 37' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -53.87 133.39 42.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.81 162.5 0.11 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 36' ' ' GLU . 23.0 pt -118.18 148.01 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.291 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -166.87 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.4 133.34 6.24 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.28 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.069 179.809 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.908 HG11 ' O ' ' A' ' 55' ' ' ASP . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.46 HG21 ' HB ' ' A' ' 15' ' ' VAL . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 59' ' ' VAL . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' HG21 ' A' ' 5' ' ' VAL . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.956 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' H ' HG22 ' A' ' 22' ' ' THR . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.532 ' HB ' HG12 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 17' ' ' VAL . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 19' ' ' ASP . 19.5 t -122.57 129.88 74.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.4 126.74 31.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.969 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.49 86.95 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.472 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 141.41 22.79 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.456 0.169 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.45 -27.52 40.43 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.928 2.419 . . . . 0.0 112.717 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.92 135.4 87.27 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.6 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.8 55.63 5.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.64 2.226 . . . . 0.0 112.167 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -13.78 60.82 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.24 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -98.82 18.96 15.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.614 0.245 . . . . 0.0 111.553 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.39 18.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 110.776 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.29 105.74 17.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.68 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.1 t 69.9 6.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.838 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 1.9 mt-10 50.84 37.16 16.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 HG22 ' HB ' ' A' ' 52' ' ' VAL . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.908 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 41' ' ' VAL . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 38' ' ' THR . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -59.75 136.15 57.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' N ' HG12 ' A' ' 37' ' ' VAL . 13.3 tp 65.54 161.66 0.14 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.84 143.29 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -140.25 154.66 46.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -162.4 30.03 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.65 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -1.311 . . . . 0.0 112.887 179.833 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 55' ' ' ASP . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 15' ' ' VAL . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG2' HG21 ' A' ' 5' ' ' VAL . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 27' ' ' VAL . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD13 HG13 ' A' ' 30' ' ' VAL . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 61' ' ' ARG . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 16' ' ' ALA . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 57' ' ' VAL . 13.7 t -123.99 129.28 74.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.27 128.54 33.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.37 86.57 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.649 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 138.01 31.99 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.488 0.185 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 91.87 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.518 2.146 . . . . 0.0 112.128 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.73 157.17 34.69 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.97 105.12 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.695 2.263 . . . . 0.0 112.642 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -13.76 62.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -5.17 49.57 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -58.63 -27.17 64.46 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.326 0.108 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 t 74.8 152.16 0.13 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 52' ' ' VAL . 8.5 t 75.82 -4.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 47.56 51.31 13.96 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG13 HG12 ' A' ' 52' ' ' VAL . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.753 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 41' ' ' VAL . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.678 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.711 ' HA ' HG11 ' A' ' 37' ' ' VAL . 16.2 ptt85 -50.69 137.68 19.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.41 32.09 6.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.1 tp -99.77 147.68 7.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 167.53 10.79 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.99 178.58 25.06 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.923 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.504 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 ' H ' ' A' ' 55' ' ' ASP . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 ' HD3' ' A' ' 56' ' ' ARG . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 57' ' ' VAL . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 60' ' ' LEU . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 5' ' ' VAL . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 39' ' ' VAL . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 17' ' ' VAL . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.72 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.599 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 38' ' ' THR . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.791 HG21 HG22 ' A' ' 17' ' ' VAL . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HG11 ' A' ' 57' ' ' VAL . 21.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.79 0.329 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.541 ' H ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HD3' HG23 ' A' ' 4' ' ' THR . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.856 HG11 HG22 ' A' ' 41' ' ' VAL . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.784 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 HG21 ' A' ' 59' ' ' VAL . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 ' CG2' ' A' ' 37' ' ' VAL . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' ASP . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.659 ' CG2' HG21 ' A' ' 15' ' ' VAL . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 HG21 ' A' ' 57' ' ' VAL . 22.1 t . . . . . 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' HG12 ' A' ' 3' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG21 HG22 ' A' ' 41' ' ' VAL . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.521 ' N ' HG12 ' A' ' 57' ' ' VAL . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 37' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' CG1' ' A' ' 37' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.675 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 55' ' ' ASP . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' HB ' ' A' ' 15' ' ' VAL . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' HG21 ' A' ' 5' ' ' VAL . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 24' ' ' ALA . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.686 ' NH2' HG12 ' A' ' 39' ' ' VAL . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 59' ' ' VAL . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.686 HG12 ' NH2' ' A' ' 28' ' ' ARG . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.2 t . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' OD1' ' A' ' 20' ' ' ASP . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 41' ' ' VAL . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 60' ' ' LEU . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 57' ' ' VAL . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.63 ' CG2' HG11 ' A' ' 59' ' ' VAL . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 16' ' ' ALA . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 HG11 ' A' ' 57' ' ' VAL . 18.7 t . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.447 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 39' ' ' VAL . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.901 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 17' ' ' VAL . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.744 ' CG1' HG22 ' A' ' 59' ' ' VAL . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.864 HG12 HG23 ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 3' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 39' ' ' VAL . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.901 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 17' ' ' VAL . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 57' ' ' VAL . 25.5 t . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' CB ' HG12 ' A' ' 3' ' ' VAL . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 41' ' ' VAL . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 57' ' ' VAL . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 37' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE2' HG11 ' A' ' 54' ' ' VAL . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 37' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 30' ' ' VAL . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.696 ' O ' HG12 ' A' ' 59' ' ' VAL . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG21 HG12 ' A' ' 17' ' ' VAL . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG22 HG11 ' A' ' 57' ' ' VAL . 22.4 t . . . . . 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 1' ' ' MET . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' A' ' 39' ' ' VAL . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 38' ' ' THR . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 57' ' ' VAL . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG21 HH12 ' A' ' 61' ' ' ARG . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 37' ' ' VAL . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' A' ' 57' ' ' VAL . 20.8 t . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 41' ' ' VAL . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.57 HH12 HG21 ' A' ' 7' ' ' VAL . 8.5 mtt85 . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 37' ' ' VAL . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG21 ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 41' ' ' VAL . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.471 HH21 HG12 ' A' ' 39' ' ' VAL . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 15' ' ' VAL . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG21 HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' ASP . 21.3 t . . . . . 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 7' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 57' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.426 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.607 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 58' ' ' LYS . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 59' ' ' VAL . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' VAL . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 37' ' ' VAL . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 28' ' ' ARG . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 20' ' ' ASP . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.773 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 32' ' ' LEU . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 15' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.601 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 59' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.587 ' HA ' HG11 ' A' ' 57' ' ' VAL . 25.7 t . . . . . 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 41' ' ' VAL . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 38' ' ' THR . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.742 ' H1 ' ' HB3' ' A' ' 24' ' ' ALA . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.972 HG12 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' VAL . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 61' ' ' ARG . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.972 HG21 HG12 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' HG11 ' A' ' 57' ' ' VAL . 26.3 t . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 41' ' ' VAL . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 39' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 37' ' ' VAL . 1.3 mtp85 . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 12' ' ' THR . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 60' ' ' LEU . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 6' ' ' GLU . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 37' ' ' VAL . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 39' ' ' VAL . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.657 ' CB ' HG11 ' A' ' 41' ' ' VAL . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.705 ' HG2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 30' ' ' VAL . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 15' ' ' VAL . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' HG12 ' A' ' 17' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.906 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 19' ' ' ASP . 86.0 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.906 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' H ' HG12 ' A' ' 57' ' ' VAL . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 7' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 8' ' ' VAL . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 . . . . . 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.817 HG11 ' O ' ' A' ' 55' ' ' ASP . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 59' ' ' VAL . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG12 HG21 ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG2' HG11 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HG12 ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 57' ' ' VAL . 36.2 t . . . . . 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 121.13 0.491 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.817 ' O ' HG11 ' A' ' 3' ' ' VAL . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 39' ' ' VAL . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.645 HG11 ' CG2' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HA ' HG11 ' A' ' 37' ' ' VAL . 2.2 ptt85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 17' ' ' VAL . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 57' ' ' VAL . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 39' ' ' VAL . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.57 ' H ' HG22 ' A' ' 22' ' ' THR . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 24' ' ' ALA . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.586 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 19' ' ' ASP . 41.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.867 0.365 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 3' ' ' VAL . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB2' HG13 ' A' ' 7' ' ' VAL . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 37' ' ' VAL . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.814 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 16' ' ' ALA . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 59' ' ' VAL . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 17' ' ' VAL . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.064 HG22 HG21 ' A' ' 57' ' ' VAL . 22.5 t . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.817 0.341 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.064 HG21 HG22 ' A' ' 41' ' ' VAL . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' HG23 ' A' ' 7' ' ' VAL . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 . . . . . 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' H ' HG22 ' A' ' 22' ' ' THR . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.823 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.823 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HG12 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 57' ' ' VAL . 16.9 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.029 0.443 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 7' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG12 HG23 ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 37' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 39' ' ' VAL . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 30' ' ' VAL . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 15' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 17' ' ' VAL . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.833 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 57' ' ' VAL . 16.6 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.883 0.373 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.755 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 HG12 ' A' ' 7' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.5 ttt180 . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 24' ' ' ALA . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' O ' ' A' ' 55' ' ' ASP . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 57' ' ' VAL . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG12 HG21 ' A' ' 39' ' ' VAL . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.606 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' H ' HG22 ' A' ' 22' ' ' THR . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 30' ' ' VAL . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 30' ' ' VAL . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 59' ' ' VAL . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.771 HG21 HG12 ' A' ' 17' ' ' VAL . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.585 ' HA ' HG11 ' A' ' 57' ' ' VAL . 21.3 t . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.89 ' O ' HG11 ' A' ' 3' ' ' VAL . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 41' ' ' VAL . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 37' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.908 HG11 ' O ' ' A' ' 55' ' ' ASP . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG21 ' HB ' ' A' ' 15' ' ' VAL . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 59' ' ' VAL . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 2' ' ' ASN . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' HG21 ' A' ' 5' ' ' VAL . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.956 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' H ' HG22 ' A' ' 22' ' ' THR . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.532 ' HB ' HG12 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 17' ' ' VAL . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 19' ' ' ASP . 19.5 t . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.908 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 41' ' ' VAL . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 38' ' ' THR . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 55' ' ' ASP . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 15' ' ' VAL . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG2' HG21 ' A' ' 5' ' ' VAL . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 27' ' ' VAL . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD13 HG13 ' A' ' 30' ' ' VAL . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 61' ' ' ARG . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 16' ' ' ALA . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 57' ' ' VAL . 13.7 t . . . . . 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.753 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 41' ' ' VAL . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.678 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.711 ' HA ' HG11 ' A' ' 37' ' ' VAL . 16.2 ptt85 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.716 0.293 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.33 126.09 33.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.658 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.541 HG11 ' H ' ' A' ' 55' ' ' ASP . 19.2 m -140.09 140.28 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 ' HD3' ' A' ' 56' ' ' ARG . 9.4 t -75.45 128.33 35.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.091 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 57' ' ' VAL . 32.0 m -118.8 137.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.32 114.29 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.038 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.63 134.26 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.627 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' A' ' 60' ' ' LEU . 40.5 t -56.5 120.24 2.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.6 -115.99 2.98 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.962 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.95 156.99 30.89 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.645 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.25 169.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.374 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -120.48 135.29 55.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.112 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -112.51 162.8 15.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.049 0.452 . . . . 0.0 111.559 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.77 121.6 45.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.886 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 5' ' ' VAL . 97.4 t -128.74 150.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 141.84 30.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.791 HG22 HG21 ' A' ' 39' ' ' VAL . 18.1 t -116.33 160.83 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.841 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 17' ' ' VAL . 3.3 t70 -112.1 -29.05 7.74 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.526 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 41' ' ' VAL . 8.9 t70 -66.9 -21.36 66.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -45.86 -40.22 9.61 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.6 74.89 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.466 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -87.07 175.29 8.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.03 0.443 . . . . 0.0 111.838 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -57.92 -36.72 72.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.881 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -56.26 -35.65 67.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 20' ' ' ASP . 5.0 m-20 -64.36 -40.1 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.199 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.27 -50.72 70.58 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.597 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.09 -32.72 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.976 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.72 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.21 -35.85 78.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.081 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.15 38.54 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.9 t -81.01 2.33 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.557 0.218 . . . . 0.0 111.097 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 52.44 67.78 0.93 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-O 121.008 0.432 . . . . 0.0 111.529 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.4 mp -103.14 33.14 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.096 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -107.16 133.06 20.47 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.808 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 -31.74 45.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.606 2.204 . . . . 0.0 112.586 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -69.85 -40.76 75.6 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 59.94 77.32 0.32 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.0 110.68 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 13.4 m -124.98 156.98 33.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.5 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 38' ' ' THR . 15.0 t -94.3 117.18 29.73 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.791 HG21 HG22 ' A' ' 17' ' ' VAL . 9.9 p -111.02 127.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.92 144.94 48.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HG11 ' A' ' 57' ' ' VAL . 21.8 t -118.96 126.6 75.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -81.52 129.79 34.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.63 80.88 0.16 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.555 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -119.55 152.31 52.93 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.76 0.314 . . . . 0.0 111.206 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.31 120.55 7.24 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.777 2.318 . . . . 0.0 112.782 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 m -148.77 151.3 35.03 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.054 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.31 44.11 1.35 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.843 2.362 . . . . 0.0 112.555 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.15 -9.3 38.45 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.523 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.12 19.15 8.28 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -97.9 -54.52 3.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.8 115.17 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.905 HG12 HG13 ' A' ' 54' ' ' VAL . 24.9 t 65.38 94.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.296 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.09 81.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.905 HG13 HG12 ' A' ' 52' ' ' VAL . 12.0 m -112.48 161.81 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.541 ' H ' HG11 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.46 141.96 24.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.146 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' HD3' HG23 ' A' ' 4' ' ' THR . 0.1 OUTLIER -95.11 125.4 39.73 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.856 HG11 HG22 ' A' ' 41' ' ' VAL . 15.8 m -136.45 168.16 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.97 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.28 138.43 39.22 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.559 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 37' ' ' VAL . 10.8 t -142.19 140.58 29.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.282 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -98.57 139.31 34.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.481 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 128.57 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.991 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.3 -173.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.07 148.28 4.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.016 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -75.53 125.35 28.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.54 -93.68 0.1 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.614 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.825 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.784 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 11.3 ptt? . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.559 0.219 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -102.49 141.14 35.79 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.448 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 m -136.69 138.6 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.13 122.72 25.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 HG21 ' A' ' 59' ' ' VAL . 6.6 m -118.65 136.16 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.47 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.47 114.37 20.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.482 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 16.7 m -81.08 134.27 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 t -56.72 120.35 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.22 -115.67 2.83 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.797 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.18 150.46 41.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 111.267 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 73.38 167.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.265 0.555 . . . . 0.0 112.259 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.9 m -127.61 135.29 50.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.043 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.22 162.26 17.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.963 0.411 . . . . 0.0 111.537 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -109.1 121.65 45.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.123 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.659 HG21 ' CG2' ' A' ' 37' ' ' VAL . 75.7 t -131.78 151.19 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.55 145.11 28.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.671 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' ASP . 31.1 m -116.22 151.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.064 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.21 -47.86 22.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.858 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.92 -21.93 33.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.099 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -48.21 -48.71 34.79 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.47 -8.35 79.95 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.506 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.35 179.64 6.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.024 0.44 . . . . 0.0 111.802 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -56.41 -31.95 64.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.922 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.7 -35.55 66.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 121.326 -0.149 . . . . 0.0 111.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -61.19 -44.89 96.57 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.487 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -61.35 -49.19 77.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.014 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 24' ' ' ALA . 15.5 m -69.89 -32.73 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.332 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.48 73.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.684 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.98 67.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.545 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.7 t -80.96 2.06 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.763 -0.198 . . . . 0.0 111.035 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 t70 52.62 67.03 1.05 Allowed 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.058 0.456 . . . . 0.0 111.498 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.24 32.47 5.79 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -103.88 129.46 25.22 Favored Pre-proline 0 C--O 1.232 0.146 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.896 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.38 -31.5 42.89 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.664 2.243 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.723 ' O ' HD23 ' A' ' 62' ' ' LEU . 11.5 m80 -78.79 -38.7 37.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.39 78.32 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.033 0.444 . . . . 0.0 111.393 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.659 ' CG2' HG21 ' A' ' 15' ' ' VAL . 27.4 m -132.83 162.22 40.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.97 117.09 30.39 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 HG12 ' A' ' 17' ' ' VAL . 11.0 p -111.1 127.87 67.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.051 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.59 129.87 53.13 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 111.428 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 HG21 ' A' ' 57' ' ' VAL . 22.1 t -118.15 128.01 75.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.7 145.35 33.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.33 85.08 0.03 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.758 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 155.18 81.81 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 120.652 0.263 . . . . 0.0 111.035 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.69 137.93 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.863 2.375 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.08 151.49 46.66 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.36 91.72 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.49 -17.98 65.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.715 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.26 16.51 5.16 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' VAL . 2.9 mm-40 -96.73 -24.56 15.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t 60.55 41.51 15.47 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.104 0.478 . . . . 0.0 110.665 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.763 HG22 HG13 ' A' ' 54' ' ' VAL . 10.7 p -150.03 -35.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.975 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.58 47.63 1.6 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 111.121 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 52' ' ' VAL . 19.4 m -105.98 162.21 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 112.077 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -149.17 145.71 27.29 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.449 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.69 125.09 39.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.007 0.432 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG21 HG22 ' A' ' 41' ' ' VAL . 40.9 t -136.76 163.74 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.521 ' N ' HG12 ' A' ' 57' ' ' VAL . 11.2 ptpt -103.1 125.92 50.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.248 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 37' ' ' VAL . 15.1 m -122.26 142.05 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.695 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.34 119.84 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.241 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HA ' ' CG1' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -53.14 140.82 24.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.249 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 35' ' ' HIS . 3.7 pp -52.67 133.75 36.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.149 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -145.21 144.46 21.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.208 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -134.65 139.0 44.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.62 -160.42 24.22 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.598 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.468 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.675 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.6 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.4 m-80 -118.36 143.58 46.52 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.715 0.293 . . . . 0.0 110.89 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 55' ' ' ASP . 4.3 t -138.92 140.72 38.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.042 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.21 116.15 15.62 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.368 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' HB ' ' A' ' 15' ' ' VAL . 24.7 m -115.99 137.05 50.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.575 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.35 114.96 27.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 8.5 m -85.63 133.93 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.58 128.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.61 -58.6 4.84 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.404 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' HG23 ' A' ' 7' ' ' VAL . 41.1 tt0 -77.84 163.92 25.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.674 0.39 . . . . 0.0 110.888 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -151.22 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -99.36 134.57 42.03 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.845 -0.534 . . . . 0.0 110.906 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -129.55 162.82 27.34 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.21 121.83 41.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.661 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' HG21 ' A' ' 5' ' ' VAL . 72.9 t -132.43 151.17 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 144.18 28.97 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.633 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 20' ' ' ASP . 4.0 m -116.15 153.83 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.91 -46.94 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.339 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -23.01 5.61 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.306 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -41.97 -48.68 4.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.04 -13.92 63.45 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.999 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -86.24 179.68 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.129 0.49 . . . . 0.0 111.76 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -55.95 -31.6 63.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.272 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.65 -35.46 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.278 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.72 -44.53 85.77 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.51 0.195 . . . . 0.0 110.774 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -45.87 89.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.144 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 24' ' ' ALA . 12.1 p -71.03 -40.62 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.951 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.686 ' NH2' HG12 ' A' ' 39' ' ' VAL . 3.4 tmt_? -62.54 -35.71 80.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.736 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.65 33.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.707 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.6 t -80.51 2.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.498 0.19 . . . . 0.0 110.968 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.2 t0 52.7 68.46 0.82 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.072 0.463 . . . . 0.0 111.9 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -105.19 30.67 5.42 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.151 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.8 m -115.47 126.88 27.3 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.949 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 -32.78 83.66 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.751 2.301 . . . . 0.0 112.709 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.66 -42.81 33.4 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.332 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 52.27 89.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.8 m -123.44 158.2 28.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.568 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 59' ' ' VAL . 1.3 m -98.39 116.81 31.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.799 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.686 HG12 ' NH2' ' A' ' 28' ' ' ARG . 11.3 p -110.08 135.51 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.848 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -117.07 125.21 50.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.793 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.2 t -129.04 129.73 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 14.9 p-10 -72.27 122.48 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.953 0.406 . . . . 0.0 110.962 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.23 87.55 0.32 Allowed Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.986 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG3' ' OD2' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -119.87 119.76 30.9 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.825 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.77 79.32 3.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.766 2.31 . . . . 0.0 112.614 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 46' ' ' VAL . 7.5 p -172.96 90.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.528 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.06 102.01 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.533 2.155 . . . . 0.0 112.382 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.0 -33.3 68.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.44 -18.46 28.26 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.42 12.21 7.15 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.22 111.07 6.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.588 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.824 HG12 HG13 ' A' ' 54' ' ' VAL . 23.4 t 72.22 108.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.31 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.9 81.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.848 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.824 HG13 HG12 ' A' ' 52' ' ' VAL . 15.6 m -126.94 162.4 31.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.43 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.872 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.17 143.98 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -93.46 124.96 37.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.138 0.494 . . . . 0.0 109.986 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 41' ' ' VAL . 7.1 m -136.89 168.61 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.28 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -101.88 126.54 48.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.583 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 47.3 t -112.58 142.29 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.41 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 60' ' ' LEU . 4.3 pp -94.4 139.55 30.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -59.81 136.62 58.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.6 mt 61.98 -170.61 0.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.1 tt -115.88 156.72 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.957 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -55.01 40.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -154.36 24.1 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.0 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.904 179.849 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 2.3 ptp . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.453 0.168 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.39 137.46 33.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.203 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.63 140.23 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 t -74.77 125.84 29.63 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.881 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 57' ' ' VAL . 27.4 m -118.67 137.52 52.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.597 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.0 OUTLIER -81.43 114.48 20.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.51 133.84 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.63 120.35 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.275 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.0 -113.76 2.34 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.887 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.18 155.66 34.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 111.573 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 170.0 0.21 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.382 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 22.1 m -124.19 135.3 53.37 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.092 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -109.71 162.79 14.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 111.57 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.37 121.76 46.08 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.9 t -129.98 150.88 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.43 144.62 28.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.343 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' HB2' ' A' ' 20' ' ' ASP . 2.9 m -116.31 150.02 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.151 0.501 . . . . 0.0 112.334 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.91 -49.87 8.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.22 -23.03 13.08 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -49.19 -43.56 42.35 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.73 72.99 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.779 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.33 179.72 6.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 111.386 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -55.76 -31.96 63.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.837 -179.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -55.63 -35.28 65.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.552 0.215 . . . . 0.0 111.022 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.3 -44.79 94.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.625 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.88 -47.47 84.83 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.948 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 24' ' ' ALA . 11.9 p -71.33 -33.44 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.049 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.7 -41.24 85.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.4 -25.37 67.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.514 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 32' ' ' LEU . 5.6 t -81.29 2.4 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.961 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 52.48 67.53 0.97 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 111.595 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.6 mp -106.49 30.41 6.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -111.61 121.81 39.02 Favored Pre-proline 0 CA--C 1.526 0.053 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.515 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.22 -32.79 88.82 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 112.559 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -79.69 -41.12 27.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.116 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 60.05 82.32 0.16 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.62 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.819 ' HA ' HD13 ' A' ' 62' ' ' LEU . 18.5 m -123.52 149.68 27.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.514 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -85.71 117.79 24.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 16' ' ' ALA . 11.4 p -109.18 134.73 50.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 HG11 ' A' ' 57' ' ' VAL . 18.7 t -123.73 131.17 73.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -81.57 127.86 33.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.647 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.79 72.11 1.07 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.383 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -118.34 133.78 23.47 Favored Pre-proline 0 C--O 1.233 0.198 0 C-N-CA 122.083 0.153 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.53 110.99 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.784 2.323 . . . . 0.0 112.267 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 48' ' ' GLU . 14.1 p -114.63 123.19 32.59 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.537 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 -15.55 38.21 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.717 2.278 . . . . 0.0 112.715 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' VAL . 19.1 mt-10 -68.49 -9.82 51.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.601 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -8.76 57.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.858 -0.155 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -69.43 -38.78 78.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.784 0.326 . . . . 0.0 110.28 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.5 m -133.36 110.73 10.24 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.948 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 54' ' ' VAL . 12.7 t 71.34 95.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.171 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -66.31 82.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.237 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 52' ' ' VAL . 11.0 m -121.15 161.28 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.039 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.08 133.47 16.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.119 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -94.56 124.63 38.71 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 39' ' ' VAL . 9.0 m -137.11 167.79 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.312 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -103.73 133.56 48.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.704 0.287 . . . . 0.0 110.551 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.63 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.7 t -129.26 142.29 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.437 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.05 126.78 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.553 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' CG ' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -57.91 133.14 55.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.115 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.819 HD13 ' HA ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -88.68 82.77 6.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.937 0.399 . . . . 0.0 110.939 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -127.68 -171.53 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.752 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 63' ' ' ILE . 13.9 mmtm -128.14 147.8 50.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.45 45.3 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.664 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.253 -1.304 . . . . 0.0 112.755 179.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.901 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -116.9 135.56 53.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 110.644 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 17' ' ' VAL . 27.6 m -127.25 140.12 49.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.345 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -75.16 113.07 12.09 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 109.948 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.744 ' CG1' HG22 ' A' ' 59' ' ' VAL . 2.5 t -119.03 137.15 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.138 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 114.73 26.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.358 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.864 HG12 HG23 ' A' ' 59' ' ' VAL . 6.1 m -80.87 125.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.12 120.78 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.226 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.03 -45.52 1.94 Allowed Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.09 165.16 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.685 0.394 . . . . 0.0 111.036 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -159.79 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.367 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.25 134.08 42.62 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 122.05 -0.406 . . . . 0.0 111.029 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.4 p -135.33 162.91 31.26 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.244 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.05 121.95 39.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG22 ' A' ' 3' ' ' VAL . 70.9 t -132.65 151.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.6 143.82 29.03 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.719 0.295 . . . . 0.0 110.663 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG11 ' A' ' 39' ' ' VAL . 1.4 m -116.02 155.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.085 0.469 . . . . 0.0 112.25 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.75 -44.44 49.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.606 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.45 -22.08 53.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -44.45 -51.12 9.0 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.83 -12.69 68.05 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.429 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -86.26 179.87 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.77 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -56.26 -31.73 63.86 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.509 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.901 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.45 -35.62 65.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.486 0.184 . . . . 0.0 110.818 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 25.9 t0 -60.58 -43.48 97.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.884 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -45.29 69.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.319 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -71.17 -41.93 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -58.85 -35.31 72.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.467 0.175 . . . . 0.0 111.148 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.38 -24.7 31.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.7 t -80.8 2.09 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.444 0.164 . . . . 0.0 111.214 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 52.0 47.87 23.89 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 111.365 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.23 36.31 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.43 146.13 35.87 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.0 -32.51 44.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.657 2.238 . . . . 0.0 112.597 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.9 -38.36 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.295 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 39.48 78.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.163 0.585 . . . . 0.0 111.902 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 59' ' ' VAL . 33.6 m -123.65 155.26 30.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.46 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 116.94 29.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 HG12 ' A' ' 17' ' ' VAL . 13.7 p -111.13 135.68 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.033 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.8 125.33 47.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 57' ' ' VAL . 25.5 t -123.35 131.21 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -80.0 130.11 35.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.0 86.49 0.06 OUTLIER Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.811 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -123.01 146.61 49.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-O 120.501 0.191 . . . . 0.0 110.794 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.65 109.95 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.83 2.353 . . . . 0.0 112.457 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 44' ' ' ARG . 21.7 t -118.21 127.07 26.82 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.649 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.31 118.62 5.23 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.656 2.237 . . . . 0.0 112.182 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.29 -24.38 63.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.148 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.63 19.21 12.71 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.604 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.0 -65.75 0.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.985 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.749 ' O ' HG22 ' A' ' 54' ' ' VAL . 45.6 t -168.02 84.08 0.19 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.701 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.71 HG13 HG13 ' A' ' 54' ' ' VAL . 9.3 p 41.02 38.28 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.95 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 54.29 52.8 11.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 51' ' ' SER . 25.3 m -106.2 161.49 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -149.8 142.8 24.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.384 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -94.81 124.69 39.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 41' ' ' VAL . 21.3 t -136.76 164.96 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 57' ' ' VAL . 13.0 ptpt -103.12 125.64 49.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.024 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.901 HG21 HG21 ' A' ' 37' ' ' VAL . 33.8 m -124.39 143.25 38.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.3 128.68 39.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.12 113.97 1.07 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mp 59.28 -176.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.562 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.92 177.53 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.34 -71.94 0.67 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.58 109.61 0.4 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.601 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.41 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.711 ' HE2' HG11 ' A' ' 54' ' ' VAL . 2.8 ptt? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.433 0.158 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.72 141.42 30.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.811 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -139.47 141.41 35.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.136 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -74.52 126.51 30.92 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.5 m -118.44 136.4 55.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.28 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HA ' HG23 ' A' ' 12' ' ' THR . 1.1 tt0 -81.53 114.24 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 31.1 m -82.56 134.34 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.442 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -56.55 120.47 3.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.481 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.64 -116.37 3.19 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.877 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.05 157.02 30.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.728 0.299 . . . . 0.0 111.398 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.27 167.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.281 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 6' ' ' GLU . 2.3 m -127.79 135.47 50.15 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.935 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -116.33 162.35 17.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.994 0.426 . . . . 0.0 111.474 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.08 121.55 44.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.816 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 37' ' ' VAL . 85.9 t -132.11 151.3 34.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.741 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.56 149.14 26.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -115.01 165.82 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.885 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.24 -31.36 8.25 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.047 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.24 -21.49 66.26 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -47.81 -43.26 27.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.12 -10.38 74.28 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.476 -0.868 . . . . 0.0 114.15 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 179.82 6.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.853 0.359 . . . . 0.0 111.227 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -31.6 62.54 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.731 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' A' ' 27' ' ' VAL . . . -55.13 -35.51 64.76 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.192 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -62.02 -45.08 95.16 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.685 0.279 . . . . 0.0 111.174 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -46.53 82.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 24' ' ' ALA . 29.2 m -67.72 -32.52 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.017 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -63.19 -35.61 80.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.017 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 -24.84 39.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.727 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 30' ' ' VAL . 17.0 t -80.78 2.51 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.313 0.101 . . . . 0.0 111.24 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 52.69 69.02 0.74 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-O 121.049 0.452 . . . . 0.0 111.915 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.9 38.63 2.22 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.942 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.65 131.74 23.51 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.58 -32.29 39.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.724 2.283 . . . . 0.0 112.968 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.29 -42.6 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.294 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 63' ' ' ILE . 2.9 mt-10 56.25 83.38 0.1 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.426 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.717 HG21 HG21 ' A' ' 15' ' ' VAL . 18.3 m -125.75 156.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.245 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.696 ' O ' HG12 ' A' ' 59' ' ' VAL . 17.6 m -84.19 116.61 23.02 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG21 HG12 ' A' ' 17' ' ' VAL . 8.3 p -110.13 125.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -122.31 127.88 50.37 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG22 HG11 ' A' ' 57' ' ' VAL . 22.4 t -122.35 127.29 75.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.532 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -81.43 126.14 31.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.762 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.16 86.2 0.8 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.479 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -114.7 144.96 32.9 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.267 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.87 63.7 6.73 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.138 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.12 147.89 35.64 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.83 -12.62 31.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.671 2.248 . . . . 0.0 112.955 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.27 -20.89 63.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.111 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -78.05 6.52 7.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -69.71 0.33 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.537 0.208 . . . . 0.0 111.0 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -96.39 110.42 22.77 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.322 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.758 HG12 HG13 ' A' ' 54' ' ' VAL . 18.8 t 70.0 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -69.8 81.65 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.066 0.46 . . . . 0.0 111.121 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG13 HG12 ' A' ' 52' ' ' VAL . 19.5 m -128.5 161.5 37.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.366 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -149.39 138.02 20.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.847 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -94.14 125.01 38.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' A' ' 39' ' ' VAL . 15.0 m -135.79 168.41 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.449 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -101.89 143.4 31.82 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.773 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 38' ' ' THR . 14.2 m -139.28 142.01 34.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.807 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.69 134.14 37.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.221 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -51.97 134.46 31.85 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.314 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt 71.32 143.81 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 36' ' ' GLU . 7.0 pt -76.07 167.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.261 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -78.56 154.91 29.99 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.5 -167.91 29.73 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.736 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.71 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 3.6 ptp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.516 0.198 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -84.73 149.17 25.96 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.66 0.267 . . . . 0.0 110.646 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.25 139.99 44.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.304 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.7 m -74.96 123.53 25.31 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 57' ' ' VAL . 20.6 m -118.39 135.48 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.748 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -81.47 114.44 20.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.305 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG21 HH12 ' A' ' 61' ' ' ARG . 28.9 m -84.91 134.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.558 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.54 120.42 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.39 -118.18 3.68 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.897 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -121.04 156.66 31.71 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.281 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.38 164.41 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.286 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -122.49 135.42 54.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.993 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -114.11 162.99 15.8 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.1 0.476 . . . . 0.0 111.934 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.27 121.56 45.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.007 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 37' ' ' VAL . 65.5 t -128.93 150.43 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.901 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.56 142.69 29.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.024 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 20' ' ' ASP . 2.5 m -115.8 165.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.103 0.477 . . . . 0.0 112.044 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -96.89 -31.7 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.67 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.46 -21.35 66.63 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 25' ' ' ASP . 20.3 p-10 -48.5 -46.32 38.19 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.04 -8.6 66.24 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 120.546 -0.835 . . . . 0.0 114.103 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.37 179.04 6.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 111.945 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -56.8 -31.81 65.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.542 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -55.69 -34.96 65.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.701 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 49.3 t0 -60.12 -44.88 94.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -50.69 73.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.38 -37.41 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.903 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 1.5 tmt_? -62.24 -35.8 80.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.019 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.79 38.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.5 t -80.67 2.47 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.393 0.14 . . . . 0.0 111.197 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 t70 52.35 68.19 0.86 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.084 0.468 . . . . 0.0 111.621 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -114.25 36.49 3.71 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 m -104.33 120.92 49.16 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.635 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.46 -32.66 90.02 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.788 2.325 . . . . 0.0 112.559 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -75.49 -41.68 54.78 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 58.5 78.17 0.26 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 110.801 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 59' ' ' VAL . 32.0 m -128.49 163.13 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.3 m -102.3 116.53 32.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.59 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.4 p -111.08 129.87 65.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -122.76 146.91 47.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.733 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' A' ' 57' ' ' VAL . 20.8 t -118.59 127.93 75.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -81.58 126.63 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.774 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.85 82.42 0.17 Allowed Glycine 0 C--N 1.336 0.56 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.617 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -123.93 149.53 60.11 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-O 120.786 0.327 . . . . 0.0 111.136 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.16 109.85 2.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.815 2.343 . . . . 0.0 112.434 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 135.36 12.65 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.36 -20.4 18.51 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.568 2.179 . . . . 0.0 112.859 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.0 -17.06 61.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.222 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.16 -4.04 59.09 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -77.7 -65.85 0.91 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' C ' HG23 ' A' ' 52' ' ' VAL . 1.4 m -81.33 125.71 30.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.443 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 54' ' ' VAL . 4.9 t 80.52 -20.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.226 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 58.99 44.8 15.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.563 HG13 HG12 ' A' ' 52' ' ' VAL . 15.2 m -109.45 162.13 7.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.354 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -149.29 143.38 25.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.837 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -95.47 124.31 39.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 41' ' ' VAL . 2.8 m -137.18 167.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.469 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -102.64 131.6 49.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.5 t -129.11 141.45 46.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 139.51 34.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.998 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.57 HH12 HG21 ' A' ' 7' ' ' VAL . 8.5 mtt85 -59.52 124.75 21.07 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 37' ' ' VAL . 0.1 OUTLIER 56.06 -168.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.099 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pt -148.24 122.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -141.52 33.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.274 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.76 -69.89 2.16 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.436 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 120.617 0.246 . . . . 0.0 111.148 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -84.82 125.79 32.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.34 139.78 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -75.17 113.48 12.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.184 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.01 132.2 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.64 121.3 27.45 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.373 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 59' ' ' VAL . 10.6 m -90.61 133.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -64.77 121.86 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.13 -25.14 25.51 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.263 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -120.37 164.72 15.92 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.488 0.315 . . . . 0.0 110.964 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -59.16 -154.48 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.339 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 132.93 44.17 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.791 -0.568 . . . . 0.0 110.884 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -128.51 162.65 26.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.247 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.65 122.01 42.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.621 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 37' ' ' VAL . 75.0 t -130.33 150.38 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.29 138.0 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG12 HG21 ' A' ' 39' ' ' VAL . 31.0 m -115.97 164.14 12.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.163 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' NH1' ' A' ' 28' ' ' ARG . 25.9 t70 -111.03 -25.77 9.6 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 41' ' ' VAL . 26.4 t70 -67.29 -25.13 65.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -46.04 -41.04 11.51 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.322 0.249 . . . . 0.0 111.458 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.78 -2.85 87.3 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.524 -0.846 . . . . 0.0 114.332 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.9 177.79 7.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.934 0.397 . . . . 0.0 111.805 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.25 -35.5 77.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.424 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 111.031 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.0 -38.31 85.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.018 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 26' ' ' LEU . 1.1 tm? -58.73 -51.27 70.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.6 p -67.67 -34.38 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.628 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.471 HH21 HG12 ' A' ' 39' ' ' VAL . 1.2 tmt_? -62.1 -36.03 80.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.797 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.77 -24.74 52.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 32' ' ' LEU . 21.2 t -80.83 2.67 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.445 0.164 . . . . 0.0 111.046 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.18 68.44 0.82 Allowed 'General case' 0 C--N 1.343 0.309 0 CA-C-O 121.223 0.535 . . . . 0.0 111.713 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -107.47 35.64 3.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.856 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -108.84 131.8 21.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 -31.59 49.58 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.614 2.209 . . . . 0.0 112.711 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -40.99 79.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.389 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 61.27 74.09 0.46 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.142 0.496 . . . . 0.0 110.438 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG12 ' H ' ' A' ' 62' ' ' LEU . 35.0 m -123.74 159.34 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.328 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.4 t -104.56 116.89 32.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.661 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG21 HG12 ' A' ' 17' ' ' VAL . 14.7 p -107.15 131.84 56.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 154.7 37.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' ASP . 21.3 t -126.08 125.41 67.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -74.48 127.52 33.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.69 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 71.54 1.08 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.733 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -110.45 144.04 29.35 Favored Pre-proline 0 C--O 1.231 0.116 0 C-N-CA 122.083 0.153 . . . . 0.0 110.765 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 52.0 Cg_exo -55.88 92.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 44' ' ' ARG . 30.1 m -140.05 146.7 47.57 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.21 86.36 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.458 2.105 . . . . 0.0 111.935 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.49 -24.53 65.38 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.38 19.27 4.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.822 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -55.25 -60.49 3.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.568 0.223 . . . . 0.0 111.4 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.4 t -154.39 128.53 8.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.799 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.937 HG13 HG13 ' A' ' 54' ' ' VAL . 12.3 p 45.33 30.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.954 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 42.72 47.65 4.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.937 HG13 HG13 ' A' ' 52' ' ' VAL . 15.9 m -106.14 162.13 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.22 143.09 25.69 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.646 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -95.02 124.66 39.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.457 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.38 167.57 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -102.95 127.53 50.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.613 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 7' ' ' VAL . 39.4 t -120.79 142.43 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.501 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.49 139.36 31.25 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.633 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -63.89 119.02 9.24 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.267 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.804 ' H ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER 59.3 176.77 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.322 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.87 134.01 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.418 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -146.7 121.9 10.18 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.04 -167.44 36.04 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.604 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.986 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 2.4 ptm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -113.37 126.96 55.94 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.1 t -124.8 141.49 44.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.91 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.82 120.03 19.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 57' ' ' VAL . 30.6 m -115.37 128.87 72.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.442 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.86 114.92 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 59' ' ' VAL . 11.8 m -86.27 130.76 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.13 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.61 125.57 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.135 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.47 -52.75 2.74 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.625 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 164.54 16.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.538 0.335 . . . . 0.0 111.075 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.51 -154.06 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.057 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.26 134.52 42.0 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.999 -0.438 . . . . 0.0 110.837 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -133.47 162.83 30.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.301 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.77 122.42 43.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.4 t -131.08 151.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.722 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 147.53 27.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.851 0.357 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' HA ' HG11 ' A' ' 39' ' ' VAL . 25.9 t -116.07 147.17 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.699 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.68 -54.67 5.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -57.01 -21.87 34.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.05 -47.13 3.06 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.551 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.02 -12.0 68.98 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.239 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.55 179.63 6.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -55.99 -32.33 63.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.522 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -54.93 -35.6 64.38 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.298 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -61.25 -45.07 96.04 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.614 0.245 . . . . 0.0 110.856 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -48.65 80.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.982 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.3 p -71.57 -33.53 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.24 73.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.38 67.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.553 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.7 t -81.41 2.03 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.577 0.227 . . . . 0.0 110.984 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 52.39 60.27 3.93 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.075 0.464 . . . . 0.0 111.442 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mp -105.69 31.08 5.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.21 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.79 132.79 21.26 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.728 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.86 -33.05 54.26 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.499 2.133 . . . . 0.0 112.308 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -79.85 -38.06 33.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.73 79.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 110.981 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 59' ' ' VAL . 34.7 m -131.86 157.17 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.402 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.607 ' O ' HG12 ' A' ' 59' ' ' VAL . 9.1 m -96.94 120.0 36.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.104 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.6 p -108.42 134.07 51.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.112 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.55 133.31 54.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.324 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.68 130.96 73.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -81.42 127.77 33.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 71.67 1.6 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.377 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -131.94 128.61 21.58 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-O 120.506 0.193 . . . . 0.0 110.989 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 138.74 80.48 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.905 2.404 . . . . 0.0 112.722 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.59 152.86 42.54 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.575 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 -16.34 36.74 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.621 2.214 . . . . 0.0 112.616 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -61.51 -17.52 55.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.529 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.9 -3.34 38.18 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -41.6 97.07 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.894 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 t -133.95 105.56 6.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 54' ' ' VAL . 10.9 t 68.97 103.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.241 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -65.29 81.22 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.957 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 15.7 m -119.92 161.24 19.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -149.53 139.75 22.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.595 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -93.84 125.14 38.29 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 58' ' ' LYS . 92.3 t -136.04 162.75 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' N ' HG12 ' A' ' 57' ' ' VAL . 6.9 ptpt -102.3 141.25 35.44 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.209 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 m -134.68 142.24 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.77 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.33 128.7 40.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -53.17 137.19 34.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.56 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -117.76 106.7 13.32 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.56 169.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -114.09 -47.44 2.95 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.109 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.23 96.29 0.15 Allowed Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.529 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.292 -1.282 . . . . 0.0 112.254 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.858 0.361 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.41 136.4 33.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.35 139.96 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -75.31 113.48 12.74 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 59' ' ' VAL . 32.6 m -113.46 134.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.55 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -85.67 115.2 23.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.269 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 59' ' ' VAL . 11.8 m -85.44 131.93 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.39 123.81 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.25 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.02 -55.87 4.03 Favored Glycine 0 C--N 1.337 0.583 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.328 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.4 164.47 24.77 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.497 0.319 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -63.15 -150.86 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 130.71 45.78 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.985 -0.447 . . . . 0.0 110.69 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -125.31 162.68 24.21 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.315 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -105.33 121.95 44.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.487 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 37' ' ' VAL . 70.3 t -127.34 150.79 33.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.896 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 28' ' ' ARG . . . -84.44 137.16 33.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 20' ' ' ASP . 10.5 m -116.12 153.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.73 -46.86 9.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.653 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -22.42 18.25 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.773 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -47.84 -45.75 30.37 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.35 -11.86 68.43 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.686 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.2 -179.78 6.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.059 0.457 . . . . 0.0 111.649 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -55.84 -31.79 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.265 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.7 66.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.57 0.224 . . . . 0.0 110.517 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 19.5 t0 -62.96 -43.66 98.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.647 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -45.71 80.71 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.067 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.6 p -71.14 -42.54 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.16 -35.38 76.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.539 0.209 . . . . 0.0 110.987 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.97 -24.85 25.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.959 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 32' ' ' LEU . 4.9 t -80.71 2.41 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.012 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.7 t0 52.91 68.31 0.85 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-O 121.153 0.501 . . . . 0.0 111.438 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.2 mp -116.79 30.61 7.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.856 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.4 p -100.54 121.04 54.42 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.763 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.78 -32.83 92.79 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.856 2.371 . . . . 0.0 112.723 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.63 -40.51 63.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.411 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.0 78.12 0.28 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.063 0.459 . . . . 0.0 110.574 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 15' ' ' VAL . 17.8 m -126.03 159.1 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.603 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.601 ' O ' HG13 ' A' ' 59' ' ' VAL . 13.8 t -102.02 116.95 33.79 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.583 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 59' ' ' VAL . 14.2 p -111.31 130.79 64.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -122.18 140.47 52.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.587 ' HA ' HG11 ' A' ' 57' ' ' VAL . 25.7 t -118.62 123.74 72.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.43 133.03 35.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.332 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.72 86.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.538 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -128.57 130.96 23.5 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-O 120.482 0.182 . . . . 0.0 111.078 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.77 131.56 42.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.912 2.408 . . . . 0.0 112.414 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.45 125.39 12.09 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.573 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.04 -14.15 21.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.725 2.283 . . . . 0.0 112.78 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.25 -12.21 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.74 -0.83 22.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -59.71 4.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.625 0.25 . . . . 0.0 110.693 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -133.3 18.99 4.0 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.631 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.78 HG12 HG22 ' A' ' 54' ' ' VAL . 25.6 t -152.09 87.05 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.428 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 80.44 0.29 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.175 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 52' ' ' VAL . 13.4 m -141.44 161.5 21.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.468 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -148.63 142.34 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.688 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.82 124.91 39.13 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.806 0.336 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 41' ' ' VAL . 4.2 m -137.15 167.74 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.56 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -102.65 130.82 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.528 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 38' ' ' THR . 14.0 t -127.16 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.247 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.13 122.33 36.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.518 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -62.89 123.11 17.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.653 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.72 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.0 mt 47.19 72.55 0.24 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 62' ' ' LEU . 9.3 tt 54.96 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.784 0.677 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -44.34 82.32 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.951 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.42 -44.26 0.23 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.622 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.347 179.681 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.742 ' H1 ' ' HB3' ' A' ' 24' ' ' ALA . 7.5 tpt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.792 0.329 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.12 143.4 28.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.52 140.13 46.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.421 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -74.7 113.43 11.96 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 15' ' ' VAL . 28.3 m -118.07 136.29 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.951 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.36 114.79 26.25 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.155 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 4.3 m -81.79 133.9 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.853 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.92 124.12 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.354 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.22 -56.03 4.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.583 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 32.8 tt0 -77.58 164.01 25.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.789 0.435 . . . . 0.0 110.715 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.58 -150.54 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.297 0.239 . . . . 0.0 111.29 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.44 133.88 43.11 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.874 -0.516 . . . . 0.0 110.801 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -131.46 162.75 29.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.239 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.11 121.78 42.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 5' ' ' VAL . 99.3 t -132.68 150.4 33.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.72 148.3 25.93 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.972 HG12 HG21 ' A' ' 39' ' ' VAL . 4.0 m -116.45 153.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.082 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t70 -86.48 -37.31 18.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' VAL . 32.3 t70 -58.4 -23.03 56.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -46.58 -54.06 10.18 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.24 -8.56 79.21 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.072 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.12 178.86 7.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.964 0.411 . . . . 0.0 112.047 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -57.06 -32.65 66.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.056 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . . . -56.47 -35.28 67.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.586 0.231 . . . . 0.0 111.003 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 18.6 t0 -67.25 -42.13 84.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.721 0.296 . . . . 0.0 110.718 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.13 -47.16 78.68 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.96 -32.39 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.708 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -60.67 -35.59 76.62 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.128 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.24 -24.59 28.56 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.2 t -80.7 2.89 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.489 0.185 . . . . 0.0 111.103 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t0 53.16 64.94 1.67 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.085 0.469 . . . . 0.0 111.872 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.73 34.28 5.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.13 121.07 51.73 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.685 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.39 -32.37 96.06 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.549 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.3 -42.72 35.82 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.754 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 54.92 72.82 0.45 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 61' ' ' ARG . 34.5 m -123.63 156.53 30.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.682 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.31 116.98 23.28 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.1 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.972 HG21 HG12 ' A' ' 17' ' ' VAL . 13.7 p -110.29 127.18 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.453 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.8 pt? -122.28 134.34 54.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' HG11 ' A' ' 57' ' ' VAL . 26.3 t -116.98 128.51 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.3 143.96 31.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.333 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.8 84.2 0.05 OUTLIER Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.877 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -130.59 121.49 19.25 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-O 120.565 0.221 . . . . 0.0 111.007 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.74 125.2 18.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.8 2.333 . . . . 0.0 112.519 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.21 152.57 41.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.072 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.11 103.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.77 2.314 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -68.3 -15.25 63.49 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.249 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.46 16.47 15.2 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -91.31 -5.88 53.97 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.33 25.44 15.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 111.101 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.991 HG22 HG13 ' A' ' 54' ' ' VAL . 7.1 p -175.52 102.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.782 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.3 78.54 1.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.991 HG13 HG22 ' A' ' 52' ' ' VAL . 12.2 m -106.24 161.99 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.619 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -149.58 141.93 24.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.779 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -94.89 124.44 38.94 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 41' ' ' VAL . 9.7 m -137.41 167.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.594 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -102.4 136.38 42.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.297 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 39' ' ' VAL . 6.0 m -125.68 142.03 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.12 135.53 39.65 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.306 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 37' ' ' VAL . 1.3 mtp85 -58.71 128.34 36.71 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.2 100.5 5.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.91 169.56 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.93 137.76 40.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.67 107.05 0.57 Allowed Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.253 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.457 -1.19 . . . . 0.0 112.312 -179.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 2.1 ptt? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -118.47 142.09 47.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.831 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.11 139.93 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.36 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 120.52 20.88 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 5.2 m -117.46 131.34 70.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.221 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 12' ' ' THR . 5.6 tt0 -81.7 114.27 20.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 59' ' ' VAL . 29.7 m -78.21 134.2 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.301 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 60' ' ' LEU . 77.3 t -56.71 120.3 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.491 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.21 -113.67 2.49 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.688 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.0 159.0 26.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.696 0.284 . . . . 0.0 111.414 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 67.96 162.03 0.19 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 6' ' ' GLU . 4.0 m -127.85 135.66 50.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.165 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -121.3 162.72 19.79 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.99 0.424 . . . . 0.0 111.995 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.25 121.99 45.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.042 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 37' ' ' VAL . 93.7 t -132.8 151.34 34.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . . . -84.94 145.92 27.51 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 110.625 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 39' ' ' VAL . 2.7 m -115.9 161.57 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.86 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -77.74 -35.89 51.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.888 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.657 ' CB ' HG11 ' A' ' 41' ' ' VAL . 8.3 t70 -63.95 -21.26 66.4 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.383 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.41 -52.02 13.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 111.143 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -11.71 64.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.584 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.33 179.01 6.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.988 0.423 . . . . 0.0 111.841 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -56.79 -32.53 65.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.67 -35.79 66.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.804 -0.18 . . . . 0.0 111.278 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 11.2 t0 -65.37 -44.51 87.37 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -44.47 78.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.194 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 24' ' ' ALA . 13.4 p -65.33 -37.5 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.512 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.705 ' HG2' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -63.8 -35.44 80.61 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.978 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.94 37.78 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 30' ' ' VAL . 21.6 t -80.76 2.65 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.925 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 52.6 68.32 0.84 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.148 0.499 . . . . 0.0 111.339 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -132.35 37.79 3.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.7 p -106.76 133.6 20.19 Favored Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.556 0.217 . . . . 0.0 110.985 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.97 -32.92 87.61 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.797 2.331 . . . . 0.0 112.42 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -79.77 -40.88 27.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 53.98 70.65 0.58 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 15' ' ' VAL . 20.3 m -129.85 146.43 34.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.924 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.8 m -96.35 117.11 30.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' HG12 ' A' ' 17' ' ' VAL . 14.6 p -110.51 135.45 49.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.952 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.906 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -106.44 156.58 18.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.996 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 19' ' ' ASP . 86.0 t -130.27 127.37 62.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.693 0.283 . . . . 0.0 110.88 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.62 129.54 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.662 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 74.09 0.92 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.425 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.23 67.65 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.587 0.232 . . . . 0.0 110.843 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.91 115.06 3.22 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.357 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.71 156.34 47.92 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.56 84.11 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.533 2.155 . . . . 0.0 112.312 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -68.05 -13.19 62.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.759 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -82.22 5.47 19.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.82 7.48 30.35 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t 73.69 127.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.488 0.315 . . . . 0.0 110.813 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 54' ' ' VAL . 12.5 t 66.87 102.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.77 80.7 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.947 0.403 . . . . 0.0 110.936 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 52' ' ' VAL . 14.4 m -108.58 161.63 6.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.413 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -149.62 143.06 25.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.64 124.45 39.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.285 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.906 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.69 168.88 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.565 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' H ' HG12 ' A' ' 57' ' ' VAL . 11.9 ptpt -101.77 139.14 37.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 7' ' ' VAL . 12.6 m -135.97 142.73 38.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.674 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 8' ' ' VAL . 6.9 mp -93.8 119.39 32.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.889 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -50.62 126.97 16.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.945 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.6 123.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.02 143.95 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 111.679 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -106.31 125.72 51.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.47 121.77 0.57 Allowed Glycine 0 C--N 1.334 0.441 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.32 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.275 -1.292 . . . . 0.0 113.07 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -118.67 135.03 54.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.743 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.817 HG11 ' O ' ' A' ' 55' ' ' ASP . 24.4 t -140.21 139.98 35.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 117.6 20.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.914 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG21 ' HB ' ' A' ' 15' ' ' VAL . 33.5 m -117.36 137.4 51.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.52 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.03 114.65 25.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.226 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 59' ' ' VAL . 4.7 m -85.3 133.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.037 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.6 129.29 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -58.47 4.98 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.73 164.44 25.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.459 0.304 . . . . 0.0 110.902 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.49 -148.95 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.973 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.31 135.03 41.32 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.97 -0.456 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -132.51 162.79 30.34 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.127 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.15 121.76 40.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.581 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 5' ' ' VAL . 75.9 t -132.89 151.49 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.526 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 28' ' ' ARG . . . -84.12 145.68 28.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.481 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG12 HG21 ' A' ' 39' ' ' VAL . 9.3 m -116.25 154.97 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.966 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -89.79 -37.37 14.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.876 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.75 -20.86 59.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.209 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -40.69 -52.43 2.93 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.303 0.377 . . . . 0.0 111.422 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.82 -11.7 71.09 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.752 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -86.24 178.97 7.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -31.91 65.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.629 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -55.67 -35.72 66.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.326 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.35 -44.34 79.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.78 0.324 . . . . 0.0 110.582 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.09 -47.52 80.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.96 -32.89 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -62.74 -35.62 80.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.865 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.72 35.23 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.781 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 32' ' ' LEU . 5.0 t -80.82 2.87 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.432 0.158 . . . . 0.0 111.195 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.78 66.6 1.17 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.0 0.428 . . . . 0.0 111.728 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.763 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -118.19 35.73 4.63 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.4 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -107.9 142.91 26.25 Favored Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.32 -32.47 50.78 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.635 2.223 . . . . 0.0 112.748 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -42.52 29.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.218 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.61 80.58 0.18 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.645 ' CG2' HG11 ' A' ' 59' ' ' VAL . 19.3 m -135.79 157.42 38.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.071 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' HD11 ' A' ' 63' ' ' ILE . 87.6 m -96.99 118.02 32.47 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.226 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.014 HG21 HG12 ' A' ' 17' ' ' VAL . 11.7 p -96.82 129.88 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.399 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.55 155.71 35.7 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.579 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 57' ' ' VAL . 36.2 t -118.44 123.11 71.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.7 140.71 35.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.54 84.49 0.1 Allowed Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -111.66 146.47 34.76 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-O 120.542 0.211 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 44' ' ' ARG . 60.8 Cg_endo -72.53 68.85 3.55 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.642 2.228 . . . . 0.0 112.252 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 46' ' ' VAL . 12.2 m -132.72 110.13 13.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.61 86.51 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.578 2.186 . . . . 0.0 112.25 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -13.46 62.32 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.612 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.94 18.56 4.1 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.08 -74.98 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.585 0.231 . . . . 0.0 110.902 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.19 132.69 53.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.432 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.69 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 p 47.19 94.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.627 0.58 . . . . 0.0 111.053 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -54.34 82.44 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.902 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 52' ' ' VAL . 22.0 m -146.7 161.72 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.817 ' O ' HG11 ' A' ' 3' ' ' VAL . 5.1 t0 -149.84 142.81 24.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.54 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -94.28 125.0 38.65 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 39' ' ' VAL . 11.2 m -137.25 167.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.488 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -102.41 134.21 46.09 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.562 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.645 HG11 ' CG2' ' A' ' 37' ' ' VAL . 20.5 t -123.96 142.45 40.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.575 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 114.14 26.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HA ' HG11 ' A' ' 37' ' ' VAL . 2.2 ptt85 -61.35 125.99 25.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.852 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt 60.34 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.59 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.647 HD11 ' HB ' ' A' ' 38' ' ' THR . 20.3 pt -142.96 147.1 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.628 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 153.32 20.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.46 117.79 5.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.604 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.55 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.839 0.352 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -84.87 138.62 32.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.298 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 17' ' ' VAL . 17.5 m -103.34 140.25 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 m -74.87 113.39 12.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.965 0.412 . . . . 0.0 110.046 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 57' ' ' VAL . 28.6 m -110.35 132.72 57.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.23 114.76 22.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.157 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 59' ' ' VAL . 6.8 m -84.26 130.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.991 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.75 120.84 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.128 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.96 -53.84 3.29 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.467 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.97 164.26 24.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.47 0.308 . . . . 0.0 111.255 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.1 tt0 -62.88 -154.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.03 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 133.07 44.36 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.971 -0.455 . . . . 0.0 110.864 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.51 162.36 29.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.354 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.21 122.04 44.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.291 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.7 t -129.81 151.09 35.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 28' ' ' ARG . . . -84.72 147.5 26.87 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 39' ' ' VAL . 20.0 t -116.54 149.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.009 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.94 -49.44 8.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.652 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -59.32 -21.66 60.07 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.886 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.98 -50.94 5.81 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.223 0.327 . . . . 0.0 111.655 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.77 -13.82 64.81 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.133 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.74 -179.89 6.64 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.768 0.318 . . . . 0.0 111.151 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.57 ' H ' HG22 ' A' ' 22' ' ' THR . 52.0 m-85 -55.98 -31.54 63.11 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -55.82 -35.42 66.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.657 0.265 . . . . 0.0 110.936 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -62.25 -44.62 96.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.707 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -46.88 77.05 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.982 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 24' ' ' ALA . 11.3 p -71.36 -33.59 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -64.36 -41.3 96.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.36 67.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.785 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.8 t -82.19 1.51 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.872 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 52.46 47.47 24.64 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -101.51 40.53 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.454 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -105.61 138.64 19.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.3 -33.03 49.89 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.504 2.136 . . . . 0.0 112.448 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 -41.0 27.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.372 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 59.73 76.85 0.34 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.43 . . . . 0.0 110.653 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.632 ' CG2' HG11 ' A' ' 59' ' ' VAL . 27.1 m -132.69 163.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.565 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.586 ' O ' HG13 ' A' ' 59' ' ' VAL . 8.5 m -98.31 116.94 31.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.479 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 17' ' ' VAL . 12.7 p -99.12 134.49 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -120.49 150.05 41.44 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.061 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' HB2' ' A' ' 19' ' ' ASP . 41.5 t -128.05 138.62 54.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.537 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.55 122.44 26.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.314 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.77 -91.14 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.497 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.6 151.05 77.47 Favored Pre-proline 0 C--O 1.232 0.174 0 C-N-CA 122.385 0.274 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.5 126.8 9.89 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 111.958 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.58 100.84 15.15 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.01 87.99 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.614 2.21 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -26.03 65.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.616 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 6.3 m-20 -85.46 -18.56 33.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.612 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 84.57 -30.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.947 0.499 . . . . 0.0 111.722 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.39 138.5 40.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 54' ' ' VAL . 18.2 t 67.33 103.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.249 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.75 78.47 0.11 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.441 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 52' ' ' VAL . 13.0 m -111.19 161.87 9.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.079 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 3' ' ' VAL . 16.0 t70 -149.62 142.52 24.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.601 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -94.28 124.91 38.6 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 39' ' ' VAL . 22.3 m -136.95 168.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.709 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -103.96 141.43 36.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.573 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 7' ' ' VAL . 26.2 t -139.21 142.27 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.375 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 135.88 36.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -59.36 128.13 35.54 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.164 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' H ' HG12 ' A' ' 37' ' ' VAL . 0.5 OUTLIER 57.8 -173.92 0.08 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 pp -123.5 156.26 29.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.22 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 138.03 39.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.86 102.25 0.75 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.591 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.789 -1.006 . . . . 0.0 113.011 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 7.3 ttt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.69 0.281 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -113.57 128.08 56.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 140.01 45.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.11 113.24 12.21 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HB ' HG23 ' A' ' 59' ' ' VAL . 19.3 m -118.15 137.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.728 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.12 115.72 28.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.301 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 59' ' ' VAL . 6.4 p -92.68 133.87 32.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.5 t -58.19 132.47 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.63 -61.41 4.7 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.482 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HB2' HG13 ' A' ' 7' ' ' VAL . 4.5 mm-40 -77.49 164.16 25.67 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.517 0.327 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.19 -154.16 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.231 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.22 132.06 44.81 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 122.029 -0.42 . . . . 0.0 110.448 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -130.18 162.89 27.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.288 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.38 121.86 41.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.298 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 37' ' ' VAL . 60.2 t -128.66 151.1 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.759 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 24' ' ' ALA . . . -84.94 138.59 32.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' ASP . 17.1 m -116.03 152.53 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.505 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 12.4 p-10 -77.44 -44.83 27.74 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.624 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.89 -21.28 57.15 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.814 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -50.67 -43.41 57.4 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.76 -9.71 76.91 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.792 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -86.11 -179.73 6.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.039 0.447 . . . . 0.0 111.627 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -55.48 -31.78 62.29 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' HB1' ' HB1' ' A' ' 16' ' ' ALA . . . -55.52 -35.75 65.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.926 -0.124 . . . . 0.0 111.32 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -63.19 -44.8 94.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.717 0.294 . . . . 0.0 110.565 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -61.05 -48.92 79.51 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.421 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 24' ' ' ALA . 19.8 m -68.51 -32.64 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.149 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -58.38 -38.28 76.96 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.448 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.81 -24.86 60.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.63 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 9.5 t -81.06 2.37 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.386 0.136 . . . . 0.0 111.29 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 53.44 62.25 2.73 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 111.594 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 33.68 3.76 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.378 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.5 m -95.96 126.24 45.44 Favored Pre-proline 0 N--CA 1.463 0.209 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.68 -32.79 66.7 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.776 2.317 . . . . 0.0 112.765 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -79.73 -39.11 31.86 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.34 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 61.5 68.53 0.71 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.591 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 59' ' ' VAL . 16.6 m -133.25 154.88 40.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.542 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 59' ' ' VAL . 21.7 m -104.28 116.63 32.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.713 HG11 HG12 ' A' ' 17' ' ' VAL . 11.9 p -110.86 136.04 48.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.17 125.06 53.52 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.838 0.352 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.064 HG22 HG21 ' A' ' 57' ' ' VAL . 22.5 t -119.73 125.7 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.757 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.56 140.52 34.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.337 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.33 84.9 0.13 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.307 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' CG ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -122.4 158.74 55.15 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 44' ' ' ARG . 52.5 Cg_endo -69.43 146.54 62.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.862 2.375 . . . . 0.0 112.835 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.05 139.1 16.39 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.732 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -51.64 107.83 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.788 2.325 . . . . 0.0 112.585 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -14.92 63.36 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.482 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -76.69 -8.71 57.8 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -15.47 62.15 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.27 27.06 12.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.923 0.392 . . . . 0.0 110.889 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.895 HG22 HG13 ' A' ' 54' ' ' VAL . 7.7 p 179.14 105.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.812 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.13 80.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 52' ' ' VAL . 12.8 m -108.36 161.67 6.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.285 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.56 143.24 25.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -94.68 125.21 39.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.064 HG21 HG22 ' A' ' 41' ' ' VAL . 23.3 t -136.27 166.32 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.157 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -106.18 130.35 54.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -131.84 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' HG23 ' A' ' 7' ' ' VAL . 4.2 mm? -93.99 139.34 31.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -59.3 128.53 37.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.43 178.33 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.2 pt -127.4 159.33 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.263 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -144.98 76.4 1.49 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.78 136.78 4.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.395 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.58 -1.122 . . . . 0.0 112.824 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 7.9 ttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.68 0.276 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -118.54 148.66 42.41 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.689 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.5 139.64 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.24 113.37 12.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 m -113.14 137.37 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.401 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 114.83 25.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.404 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 59' ' ' VAL . 12.0 m -89.02 133.86 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 t -58.57 132.9 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.445 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.15 -60.47 4.8 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -77.61 164.22 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.376 0.27 . . . . 0.0 110.923 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 tt0 -61.72 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.59 133.96 43.17 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.816 -0.552 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.32 162.66 25.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.146 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.41 121.92 42.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.467 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.08 151.03 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 136.23 33.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.721 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 39' ' ' VAL . 16.4 m -116.1 155.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.501 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.7 -38.53 16.9 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.951 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.37 -21.55 60.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -44.98 -47.33 11.45 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.765 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.88 -10.94 73.42 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.225 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.35 179.62 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.834 0.349 . . . . 0.0 111.258 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' H ' HG22 ' A' ' 22' ' ' THR . 39.5 m-85 -56.3 -31.71 63.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.512 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.56 -35.41 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -63.53 -44.82 93.12 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 110.798 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -47.73 84.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.804 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.22 -33.47 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.158 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -40.98 97.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.793 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.11 -24.76 66.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.467 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.823 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.8 t -80.85 2.59 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.163 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.53 68.13 0.87 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.179 0.514 . . . . 0.0 111.369 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.823 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.7 mt -126.93 35.4 4.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 124.46 35.12 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.741 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.5 -32.77 75.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.718 2.279 . . . . 0.0 112.6 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -42.26 62.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.952 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 56.25 78.59 0.2 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 62' ' ' LEU . 27.5 m -133.99 152.64 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -96.26 116.94 29.81 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.488 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HG12 ' A' ' 17' ' ' VAL . 13.0 p -111.06 132.81 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.68 148.69 44.99 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 HG11 ' A' ' 57' ' ' VAL . 16.9 t -127.36 130.8 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -80.89 127.04 32.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.599 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.32 87.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.719 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -131.32 142.36 45.17 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-O 120.426 0.155 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 98.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.748 2.298 . . . . 0.0 112.122 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.1 p -106.4 105.64 54.94 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.6 -12.09 32.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.579 2.186 . . . . 0.0 112.739 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -60.67 -18.73 55.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.588 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.1 p30 -77.93 1.53 20.34 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.62 -55.53 25.04 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.516 0.198 . . . . 0.0 110.971 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -125.22 26.06 7.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.681 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 54' ' ' VAL . 7.5 p -176.3 99.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 120.938 0.399 . . . . 0.0 110.477 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -69.55 78.12 0.41 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.446 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 52' ' ' VAL . 12.8 m -140.52 161.85 24.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -149.36 143.29 25.68 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.686 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -95.0 124.7 39.2 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 41' ' ' VAL . 3.1 m -137.08 167.51 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.543 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.29 133.97 46.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 7' ' ' VAL . 22.0 t -131.67 142.21 43.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.38 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.65 134.29 37.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.31 131.94 33.55 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.211 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.3 mp 61.76 168.02 0.11 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.7 pt -104.21 136.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.933 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -60.52 -43.69 96.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.79 -91.24 0.08 OUTLIER Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.322 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.502 -1.165 . . . . 0.0 112.729 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 13.7 ttt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.587 0.232 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.01 147.76 36.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG11 ' O ' ' A' ' 55' ' ' ASP . 2.0 t -137.63 140.72 40.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.027 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.0 113.47 12.36 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.39 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 15' ' ' VAL . 16.1 m -117.95 131.97 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.234 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.52 114.66 22.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG12 HG23 ' A' ' 59' ' ' VAL . 10.6 m -84.39 129.27 37.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.06 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -59.4 123.84 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.8 -53.71 1.95 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.433 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.74 164.65 16.6 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.697 0.399 . . . . 0.0 111.267 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.32 -156.88 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.277 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.4 134.92 41.57 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.888 -0.508 . . . . 0.0 111.092 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.7 t -135.78 163.01 31.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.267 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -97.45 121.85 39.83 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.784 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 37' ' ' VAL . 76.3 t -132.99 151.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.577 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.17 147.44 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 39' ' ' VAL . 15.8 m -115.96 152.0 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.267 0.555 . . . . 0.0 112.409 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.84 -47.21 22.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.397 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 21.8 t70 -54.41 -25.89 27.36 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.248 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -42.21 -50.56 4.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.44 0.296 . . . . 0.0 111.598 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.71 -11.2 72.77 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.472 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.19 179.48 6.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.924 0.393 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.13 -31.35 63.25 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -55.36 -35.18 64.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.049 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.68 -44.74 77.09 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.968 0.414 . . . . 0.0 110.178 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.35 -48.98 78.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.64 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 24' ' ' ALA . 14.8 p -69.33 -34.63 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -35.78 78.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.719 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.53 -24.68 33.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.767 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 30' ' ' VAL . 5.0 t -80.96 2.71 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.462 0.173 . . . . 0.0 111.24 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 52.47 66.41 1.22 Allowed 'General case' 0 C--N 1.345 0.371 0 C-N-CA 122.752 0.421 . . . . 0.0 111.931 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.11 32.99 5.84 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.317 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.1 t -103.93 124.8 36.41 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.656 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 -32.14 67.88 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.645 2.23 . . . . 0.0 112.663 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -78.61 -37.81 41.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.522 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 56.28 69.45 0.74 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.732 0.301 . . . . 0.0 111.224 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 15' ' ' VAL . 8.0 m -125.57 147.77 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 111.734 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 64' ' ' LYS . 12.7 t -97.76 121.86 40.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.528 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 17' ' ' VAL . 12.0 p -108.63 135.75 46.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.833 ' O ' HG11 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -115.35 125.65 53.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.164 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 57' ' ' VAL . 16.6 t -120.61 130.89 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.708 0.29 . . . . 0.0 111.188 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.81 123.26 28.64 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.304 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.6 74.17 2.54 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.427 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -123.18 157.17 61.8 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.565 0.221 . . . . 0.0 110.949 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.08 106.84 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.023 2.482 . . . . 0.0 112.886 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.44 146.95 31.78 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 -10.99 25.04 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.804 2.336 . . . . 0.0 112.892 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.96 -21.43 61.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.212 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.57 19.17 2.05 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -113.08 -69.17 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.616 0.246 . . . . 0.0 110.569 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 m -85.47 98.78 10.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 54' ' ' VAL . 12.2 t 70.3 105.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.532 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.21 79.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.158 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 52' ' ' VAL . 15.6 m -150.7 161.88 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.254 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.755 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -149.42 141.06 23.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.515 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -93.81 124.18 37.64 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -137.68 168.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.487 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -101.82 141.85 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.067 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.906 HG23 HG12 ' A' ' 7' ' ' VAL . 35.4 m -134.7 141.95 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.977 0.418 . . . . 0.0 111.994 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.07 139.63 32.78 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.5 ttt180 -50.91 140.34 15.49 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 72.26 175.26 0.28 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.5 tp -84.7 144.26 10.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.928 0.394 . . . . 0.0 111.212 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HB2' HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -105.9 172.96 6.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.66 -146.54 12.28 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.917 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.505 -1.164 . . . . 0.0 112.559 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 24' ' ' ALA . 16.4 ptm . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -84.75 133.9 34.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.604 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' O ' ' A' ' 55' ' ' ASP . 46.2 t -115.48 140.14 38.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -75.36 119.82 19.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.032 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 57' ' ' VAL . 33.6 m -118.65 135.73 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.475 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.1 116.39 22.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.5 m -81.27 125.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.9 t -60.13 120.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.85 -15.24 56.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.223 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -120.77 164.67 16.25 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.464 0.306 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.78 -149.87 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.854 0.359 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 132.15 45.18 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 121.648 -0.658 . . . . 0.0 111.038 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 p -129.65 162.64 27.85 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.43 121.95 43.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.56 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.02 150.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.674 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 28' ' ' ARG . . . -84.97 143.4 28.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.004 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG12 HG21 ' A' ' 39' ' ' VAL . 3.5 m -116.57 151.83 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.876 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -90.67 -44.51 9.45 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.663 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -22.14 24.35 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.427 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.606 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -41.99 -50.83 4.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.73 -10.57 74.31 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.719 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -85.99 179.29 7.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 111.466 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' H ' HG22 ' A' ' 22' ' ' THR . 68.5 m-85 -56.55 -32.56 65.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.875 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . . . -56.03 -35.67 67.13 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.601 0.239 . . . . 0.0 111.112 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -64.03 -44.6 92.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -56.83 -47.31 80.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.988 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.0 -32.88 53.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.034 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -59.52 -35.56 74.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -24.81 28.32 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 30' ' ' VAL . 22.2 t -80.7 2.73 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.516 0.198 . . . . 0.0 111.011 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 t0 52.6 68.33 0.84 Allowed 'General case' 0 C--N 1.344 0.364 0 CA-C-O 121.139 0.495 . . . . 0.0 111.614 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 30' ' ' VAL . 2.8 mm? -97.89 -11.51 23.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.609 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 3.1 p -74.11 120.58 82.05 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-O 120.435 0.16 . . . . 0.0 110.809 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 22.3 Cg_exo -64.48 -32.58 59.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.688 2.259 . . . . 0.0 112.515 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -42.18 89.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 63' ' ' ILE . 13.6 tt0 56.21 77.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.638 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 59' ' ' VAL . 14.1 m -124.54 156.94 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.573 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -91.7 117.1 29.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.771 HG21 HG12 ' A' ' 17' ' ' VAL . 13.2 p -110.96 130.99 63.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 153.83 38.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.585 ' HA ' HG11 ' A' ' 57' ' ' VAL . 21.3 t -124.41 126.27 71.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -81.38 130.98 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.576 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.15 83.06 0.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.387 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -130.39 155.65 80.69 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-O 120.792 0.33 . . . . 0.0 111.163 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 141.75 45.65 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 48' ' ' GLU . 12.1 p -162.54 128.02 2.2 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.297 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.14 -15.17 47.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.643 2.229 . . . . 0.0 112.894 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.687 ' H ' HG22 ' A' ' 46' ' ' VAL . 30.2 mm-40 -66.99 -13.74 62.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.379 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.15 -17.79 59.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.24 -53.11 11.7 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.714 0.292 . . . . 0.0 110.415 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.24 115.91 30.55 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.186 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 54' ' ' VAL . 18.0 t 70.37 100.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.215 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -65.28 81.81 0.05 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.396 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 52' ' ' VAL . 15.5 m -136.0 161.49 37.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.469 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.89 ' O ' HG11 ' A' ' 3' ' ' VAL . 25.8 m-20 -149.53 141.45 23.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.481 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -94.26 125.21 38.76 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 41' ' ' VAL . 15.4 m -136.8 167.87 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -102.35 132.99 47.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 37' ' ' VAL . 22.0 t -124.66 142.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 120.83 34.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -53.87 133.39 42.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.81 162.5 0.11 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 36' ' ' GLU . 23.0 pt -118.18 148.01 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.291 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -166.87 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.4 133.34 6.24 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.28 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.069 179.809 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.832 0.348 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -92.36 144.61 25.2 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.574 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.908 HG11 ' O ' ' A' ' 55' ' ' ASP . 40.2 t -134.02 140.28 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.441 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.37 116.08 15.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.928 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.46 HG21 ' HB ' ' A' ' 15' ' ' VAL . 35.0 m -118.34 135.12 59.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.388 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.8 114.82 22.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.238 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 59' ' ' VAL . 5.2 m -85.08 124.62 40.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.0 120.78 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.307 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.07 -20.93 42.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.203 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -117.65 164.61 14.71 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.527 0.331 . . . . 0.0 110.59 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.12 -149.35 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 132.42 44.97 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.935 -0.478 . . . . 0.0 110.77 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 t -132.8 162.61 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.15 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 2' ' ' ASN . 21.3 mt-10 -102.76 121.91 43.42 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.351 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' HG21 ' A' ' 5' ' ' VAL . 70.6 t -130.05 150.65 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.684 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' CB ' ' HD3' ' A' ' 28' ' ' ARG . . . -85.26 147.32 26.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.82 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.956 HG12 HG21 ' A' ' 39' ' ' VAL . 13.8 m -116.41 152.6 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.718 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.04 -41.31 13.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -56.41 -21.74 27.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.922 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' HB2' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -44.54 -55.87 4.79 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.119 0.262 . . . . 0.0 111.483 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.96 -8.16 80.35 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.653 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -86.25 175.62 8.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.382 . . . . 0.0 111.602 -178.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' H ' HG22 ' A' ' 22' ' ' THR . 0.2 OUTLIER -56.94 -32.68 66.23 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.045 -179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . . . -55.96 -35.35 66.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.549 0.214 . . . . 0.0 111.083 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -66.94 -41.92 86.18 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 110.373 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 tp -56.69 -46.63 81.07 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 24' ' ' ALA . 10.9 p -66.14 -33.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.674 0.274 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -61.57 -35.63 78.34 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.095 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.11 -24.64 26.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.86 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.7 t -80.68 2.43 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.436 0.16 . . . . 0.0 111.09 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t0 52.58 68.2 0.86 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 111.627 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.88 34.45 4.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.773 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.69 127.91 27.2 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.58 -31.92 40.13 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.473 2.115 . . . . 0.0 112.406 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -41.5 25.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.648 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 56.25 80.24 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.939 0.399 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.532 ' HB ' HG12 ' A' ' 59' ' ' VAL . 4.8 m -123.94 151.44 28.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.654 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 59' ' ' VAL . 12.3 t -90.44 117.0 28.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.956 HG21 HG12 ' A' ' 17' ' ' VAL . 11.6 p -104.16 131.61 52.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.44 143.37 49.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 19' ' ' ASP . 19.5 t -122.57 129.88 74.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.4 126.74 31.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.969 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.49 86.95 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.472 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.34 141.41 22.79 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.456 0.169 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.45 -27.52 40.43 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.928 2.419 . . . . 0.0 112.717 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.92 135.4 87.27 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.6 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.8 55.63 5.75 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.64 2.226 . . . . 0.0 112.167 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -13.78 60.82 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.24 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -98.82 18.96 15.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.614 0.245 . . . . 0.0 111.553 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -36.39 18.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.587 0.232 . . . . 0.0 110.776 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.29 105.74 17.93 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.68 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 52' ' ' VAL . 13.1 t 69.9 6.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.838 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 1.9 mt-10 50.84 37.16 16.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 HG22 ' HB ' ' A' ' 52' ' ' VAL . 16.3 m -113.93 162.11 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.802 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.908 ' O ' HG11 ' A' ' 3' ' ' VAL . 18.3 t0 -149.26 141.26 23.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.102 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -93.81 125.33 38.37 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 41' ' ' VAL . 10.6 m -137.13 168.43 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.654 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -102.43 127.84 49.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 38' ' ' THR . 10.6 t -120.04 141.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.203 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.58 136.35 34.99 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.664 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -59.75 136.15 57.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.085 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' N ' HG12 ' A' ' 37' ' ' VAL . 13.3 tp 65.54 161.66 0.14 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.84 143.29 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -140.25 154.66 46.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -162.4 30.03 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.65 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.24 -1.311 . . . . 0.0 112.887 179.833 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 ptm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -115.41 136.36 53.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 55' ' ' ASP . 1.7 t -138.01 140.84 39.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.38 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.97 129.64 37.99 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.275 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' CG2' ' A' ' 15' ' ' VAL . 27.6 m -117.86 137.27 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.277 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.4 tm-20 -81.35 114.24 19.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.072 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.91 134.0 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 t -56.91 120.49 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.1 -118.65 3.2 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.967 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.89 151.44 39.66 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 111.426 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.72 166.2 0.21 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.434 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.6 m -115.38 135.48 54.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.094 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -107.19 162.62 13.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 111.561 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -111.18 121.68 45.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.055 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG2' HG21 ' A' ' 5' ' ' VAL . 65.6 t -131.34 150.98 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.762 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' O ' HG11 ' A' ' 39' ' ' VAL . . . -84.42 148.27 26.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.387 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.54 136.24 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.271 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -77.99 -39.49 42.12 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.977 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.79 -27.71 63.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.27 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.66 -48.66 4.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.074 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.15 -9.23 78.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.281 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 p -86.26 179.71 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.025 0.441 . . . . 0.0 111.684 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -56.19 -31.58 63.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 27' ' ' VAL . . . -55.7 -35.42 66.05 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.383 0.135 . . . . 0.0 111.307 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -61.66 -44.56 96.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 110.591 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -47.36 85.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.894 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 30' ' ' VAL . 13.2 p -70.15 -36.39 67.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.165 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.87 -35.89 79.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.979 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.55 61.67 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 27' ' ' VAL . 7.8 p -81.07 2.48 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.33 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t0 52.24 65.68 1.43 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-O 121.006 0.431 . . . . 0.0 111.772 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD13 HG13 ' A' ' 30' ' ' VAL . 3.8 mp -119.75 31.57 6.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.183 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 134.46 23.28 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.727 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.38 -33.07 75.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.68 2.254 . . . . 0.0 112.614 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 -42.19 25.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.918 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 56.16 77.78 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.796 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 61' ' ' ARG . 19.0 m -134.36 165.35 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.962 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 59' ' ' VAL . 5.6 m -96.06 117.95 31.69 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.882 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 16' ' ' ALA . 9.0 p -107.42 131.15 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.208 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 146.46 47.42 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 57' ' ' VAL . 13.7 t -123.99 129.28 74.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -81.27 128.54 33.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.664 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.37 86.57 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.649 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 138.01 31.99 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-O 120.488 0.185 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 91.87 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.518 2.146 . . . . 0.0 112.128 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.73 157.17 34.69 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.97 105.12 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.695 2.263 . . . . 0.0 112.642 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -13.76 62.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -5.17 49.57 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -58.63 -27.17 64.46 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 120.326 0.108 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 t 74.8 152.16 0.13 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 52' ' ' VAL . 8.5 t 75.82 -4.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.073 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 47.56 51.31 13.96 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 111.314 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG13 HG12 ' A' ' 52' ' ' VAL . 12.0 m -106.04 162.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.296 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.753 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -148.95 143.35 26.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.672 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -94.44 125.08 38.86 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 41' ' ' VAL . 3.3 m -136.83 167.92 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.193 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -102.13 143.38 32.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 111.131 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.678 HG11 ' CG2' ' A' ' 37' ' ' VAL . 21.8 t -140.35 142.49 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 109.51 21.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.711 ' HA ' HG11 ' A' ' 37' ' ' VAL . 16.2 ptt85 -50.69 137.68 19.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.815 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -115.41 32.09 6.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.1 tp -99.77 147.68 7.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.43 167.53 10.79 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.99 178.58 25.06 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.923 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.504 179.939 . . . . . . . . 0 0 . 1 stop_ save_